Application,Product,Drug,NDA,Marketing,Sponsor,Form,Strength,Ingredient,DocumentType,DocumentDate,DocumentURL
4782,1,PREMARIN,N004782,Prescription,WYETH PHARMS,TABLET (ORAL),1.25MG,"ESTROGENS, CONJUGATED",Other Important Information from FDA,2009-06-02T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103324.htm
4782,2,PREMARIN,N004782,Discontinued,WYETH PHARMS,TABLET (ORAL),2.5MG,"ESTROGENS, CONJUGATED",Other Important Information from FDA,2009-06-02T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103324.htm
4782,3,PREMARIN,N004782,Prescription,WYETH PHARMS,TABLET (ORAL),0.3MG,"ESTROGENS, CONJUGATED",Other Important Information from FDA,2009-06-02T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103324.htm
4782,4,PREMARIN,N004782,Prescription,WYETH PHARMS,TABLET (ORAL),0.625MG,"ESTROGENS, CONJUGATED",Other Important Information from FDA,2009-06-02T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103324.htm
4782,5,PREMARIN,N004782,Prescription,WYETH PHARMS,TABLET (ORAL),0.9MG,"ESTROGENS, CONJUGATED",Other Important Information from FDA,2009-06-02T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103324.htm
4782,6,PREMARIN,N004782,Prescription,WYETH PHARMS,TABLET (ORAL),0.45MG,"ESTROGENS, CONJUGATED",Other Important Information from FDA,2009-06-02T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103324.htm
5939,1,BAL,N005939,Prescription,AKORN,INJECTABLE (INJECTION),10%,DIMERCAPROL,,,
6188,1,PROPYLTHIOURACIL,N006188,Prescription,DAVA PHARMS INC,TABLET (ORAL),50MG,PROPYLTHIOURACIL,,,
8922,1,CALCIUM DISODIUM VERSENATE,N008922,Prescription,BAUSCH,INJECTABLE (INJECTION),200MG/ML,EDETATE CALCIUM DISODIUM,,,
8922,2,CALCIUM DISODIUM VERSENATE,N008922,Discontinued,BAUSCH,TABLET (ORAL),500MG,EDETATE CALCIUM DISODIUM,,,
9190,1,LIPIODOL,N009190,Prescription,GUERBET,"OIL (INTRALYMPHATIC, INTRAUTERINE)",EQ 4.8GM IODINE/10ML (EQ 480MG IODINE/ML),ETHIODIZED OIL,,,
9386,1,MYLERAN,N009386,Prescription,ASPEN GLOBAL,TABLET (ORAL),2MG,BUSULFAN,,,
9435,1,NESACAINE,N009435,Prescription,FRESENIUS KABI USA,INJECTABLE (INJECTION),1%,CHLOROPROCAINE HYDROCHLORIDE,,,
9435,2,NESACAINE,N009435,Prescription,FRESENIUS KABI USA,INJECTABLE (INJECTION),2%,CHLOROPROCAINE HYDROCHLORIDE,,,
9435,3,NESACAINE-MPF,N009435,Discontinued,FRESENIUS KABI USA,INJECTABLE (INJECTION),2%,CHLOROPROCAINE HYDROCHLORIDE,,,
9435,4,NESACAINE-MPF,N009435,Discontinued,FRESENIUS KABI USA,INJECTABLE (INJECTION),3%,CHLOROPROCAINE HYDROCHLORIDE,,,
9435,6,NESACAINE-MPF,N009435,Prescription,FRESENIUS KABI USA,INJECTABLE (INJECTION),2%,CHLOROPROCAINE HYDROCHLORIDE,,,
9435,7,NESACAINE-MPF,N009435,Prescription,FRESENIUS KABI USA,INJECTABLE (INJECTION),3%,CHLOROPROCAINE HYDROCHLORIDE,,,
10402,1,PREMARIN,N010402,Prescription,WYETH PHARMS,INJECTABLE (INJECTION),25MG/VIAL,"ESTROGENS, CONJUGATED",Other Important Information from FDA,2009-06-02T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103324.htm
10596,7,CELONTIN,N010596,Discontinued,PARKE DAVIS,CAPSULE (ORAL),150MG,METHSUXIMIDE,Medication Guide,2010-10-13T00:00:00Z,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf
10596,8,CELONTIN,N010596,Prescription,PARKE DAVIS,CAPSULE (ORAL),300MG,METHSUXIMIDE,Medication Guide,2010-10-13T00:00:00Z,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf
10669,2,LEUKERAN,N010669,Prescription,ASPEN GLOBAL INC,TABLET (ORAL),2MG,CHLORAMBUCIL,,,
11559,1,BREVITAL SODIUM,N011559,Prescription,PAR STERILE PRODUCTS,INJECTABLE (INJECTION),500MG/VIAL,METHOHEXITAL SODIUM,,,
11559,2,BREVITAL SODIUM,N011559,Discontinued,PAR STERILE PRODUCTS,INJECTABLE (INJECTION),2.5GM/VIAL,METHOHEXITAL SODIUM,,,
11559,3,BREVITAL SODIUM,N011559,Discontinued,PAR STERILE PRODUCTS,INJECTABLE (INJECTION),5GM/VIAL,METHOHEXITAL SODIUM,,,
11559,4,BREVITAL SODIUM,N011559,Discontinued,PAR STERILE PRODUCTS,INJECTABLE (INJECTION),200MG/VIAL,METHOHEXITAL SODIUM,,,
11870,1,DIURIL,N011870,Prescription,SALIX PHARMS,SUSPENSION (ORAL),250MG/5ML,CHLOROTHIAZIDE,,,
11961,1,MARPLAN,N011961,Prescription,VALIDUS PHARMS INC,TABLET (ORAL),10MG,ISOCARBOXAZID,Other Important Information from FDA,2007-05-09T00:00:00Z,http://www.fda.gov/cder/drug/antidepressants/default.htm
11963,1,PHOSPHOLINE IODIDE,N011963,Prescription,WYETH PHARMS,FOR SOLUTION (OPHTHALMIC),0.13%,ECHOTHIOPHATE IODIDE,,,
11963,2,PHOSPHOLINE IODIDE,N011963,Discontinued,WYETH PHARMS,FOR SOLUTION (OPHTHALMIC),0.03%,ECHOTHIOPHATE IODIDE,,,
11963,3,PHOSPHOLINE IODIDE,N011963,Discontinued,WYETH PHARMS,FOR SOLUTION (OPHTHALMIC),0.25%,ECHOTHIOPHATE IODIDE,,,
11963,4,PHOSPHOLINE IODIDE,N011963,Discontinued,WYETH PHARMS,FOR SOLUTION (OPHTHALMIC),0.06%,ECHOTHIOPHATE IODIDE,,,
12429,1,THIOGUANINE,N012429,Prescription,ASPEN GLOBAL INC,TABLET (ORAL),40MG,THIOGUANINE,,,
12541,2,DEPO-PROVERA,N012541,Discontinued,PFIZER,INJECTABLE (INJECTION),100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,MEDROXYPROGESTERONE ACETATE,,,
12541,3,DEPO-PROVERA,N012541,Discontinued,PFIZER,INJECTABLE (INJECTION),400MG/ML,MEDROXYPROGESTERONE ACETATE,,,
12616,4,ALDACTAZIDE,N012616,Prescription,PFIZER,TABLET (ORAL),25MG;25MG,HYDROCHLOROTHIAZIDE; SPIRONOLACTONE,,,
12616,5,ALDACTAZIDE,N012616,Prescription,PFIZER,TABLET (ORAL),50MG;50MG,HYDROCHLOROTHIAZIDE; SPIRONOLACTONE,,,
13025,1,THAM-E,N013025,Discontinued,HOSPIRA,INJECTABLE (INJECTION),370MG/VIAL;1.75GM/VIAL;36GM/VIAL,TROMETHAMINE,,,
13025,2,THAM,N013025,Prescription,HOSPIRA,SOLUTION (INJECTION),18GM/500ML (3.6GM/100ML),TROMETHAMINE,,,
13026,2,TRECATOR,N013026,Prescription,WYETH PHARMS,TABLET (ORAL),250MG,ETHIONAMIDE,,,
14134,1,PROTOPAM CHLORIDE,N014134,Prescription,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),1GM/VIAL,PRALIDOXIME CHLORIDE,,,
16295,1,HYDREA,N016295,Prescription,BRISTOL MYERS SQUIBB,CAPSULE (ORAL),500MG,HYDROXYUREA,,,
16295,2,DROXIA,N016295,Prescription,BRISTOL MYERS SQUIBB,CAPSULE (ORAL),200MG,HYDROXYUREA,,,
16295,3,DROXIA,N016295,Prescription,BRISTOL MYERS SQUIBB,CAPSULE (ORAL),300MG,HYDROXYUREA,,,
16295,4,DROXIA,N016295,Prescription,BRISTOL MYERS SQUIBB,CAPSULE (ORAL),400MG,HYDROXYUREA,,,
16466,1,ARISTOSPAN,N016466,Prescription,SANDOZ INC,INJECTABLE (INJECTION),5MG/ML,TRIAMCINOLONE HEXACETONIDE,,,
16466,2,ARISTOSPAN,N016466,Prescription,SANDOZ INC,INJECTABLE (INJECTION),20MG/ML,TRIAMCINOLONE HEXACETONIDE,,,
16741,1,SORBITOL 3.3% IN PLASTIC CONTAINER,N016741,Prescription,B BRAUN,SOLUTION (IRRIGATION),3.3GM/100ML,SORBITOL,,,
16785,1,MATULANE,N016785,Prescription,LEADIANT BIOSCI INC,CAPSULE (ORAL),EQ 50MG BASE,PROCARBAZINE HYDROCHLORIDE,,,
16822,1,FREAMINE 8.5%,N016822,Discontinued,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS,,,
16822,1,FREAMINE 8.5%,N016822,Discontinued,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE,,,
16822,1,FREAMINE 8.5%,N016822,Discontinued,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
16822,2,FREAMINE II 8.5%,N016822,Discontinued,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS,,,
16822,2,FREAMINE II 8.5%,N016822,Discontinued,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE,,,
16822,2,FREAMINE II 8.5%,N016822,Discontinued,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
16822,3,FREAMINE III 3% W/ ELECTROLYTES,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML,AMINO ACIDS,,,
16822,3,FREAMINE III 3% W/ ELECTROLYTES,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML,AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE,,,
16822,3,FREAMINE III 3% W/ ELECTROLYTES,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML,AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
16822,4,FREAMINE III 8.5%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS,,,
16822,4,FREAMINE III 8.5%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE,,,
16822,4,FREAMINE III 8.5%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
16822,5,FREAMINE III 10%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),10% (10GM/100ML),AMINO ACIDS,,,
16822,5,FREAMINE III 10%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),10% (10GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE,,,
16822,5,FREAMINE III 10%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),10% (10GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
16822,6,FREAMINE HBC 6.9%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),6.9% (6.9GM/100ML),AMINO ACIDS,,,
16822,6,FREAMINE HBC 6.9%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),6.9% (6.9GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE,,,
16822,6,FREAMINE HBC 6.9%,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),6.9% (6.9GM/100ML),AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
16822,7,FREAMINE III 8.5% W/ ELECTROLYTES,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML,AMINO ACIDS,,,
16822,7,FREAMINE III 8.5% W/ ELECTROLYTES,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML,AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE,,,
16822,7,FREAMINE III 8.5% W/ ELECTROLYTES,N016822,Prescription,B BRAUN,INJECTABLE (INJECTION),8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML,AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
16848,1,ANADROL-50,N016848,Discontinued,MYLAN SPECIALITY LP,TABLET (ORAL),50MG,OXYMETHOLONE,,,
16885,1,LYSODREN,N016885,Prescription,HRA PHARMA,TABLET (ORAL),500MG,MITOTANE,,,
16931,1,R-GENE 10,N016931,Prescription,PHARMACIA AND UPJOHN,INJECTABLE (INJECTION),10GM/100ML,ARGININE HYDROCHLORIDE,,,
16988,1,FLUOROPLEX,N016988,Prescription,ALMIRALL,CREAM (TOPICAL),1%,FLUOROURACIL,,,
17351,1,CORTIFOAM,N017351,Prescription,MYLAN SPECIALITY LP,"AEROSOL, METERED (RECTAL)",10%,HYDROCORTISONE ACETATE,,,
17378,1,PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER,N017378,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML,MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,,,
17378,2,PLASMA-LYTE A IN PLASTIC CONTAINER,N017378,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML,MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,,,
17484,1,DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER,N017484,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;31MG/100ML;141MG/100ML;20MG/100ML;12MG/100ML;260MG/100ML,"DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE",,,
17586,1,NORMOSOL-R IN PLASTIC CONTAINER,N017586,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),30MG/100ML;37MG/100ML;222MG/100ML;526MG/100ML;502MG/100ML,MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,,,
17588,1,GLEOSTINE,N017588,Prescription,CORDEN PHARMA,CAPSULE (ORAL),10MG,LOMUSTINE,,,
17588,2,GLEOSTINE,N017588,Prescription,CORDEN PHARMA,CAPSULE (ORAL),40MG,LOMUSTINE,,,
17588,3,GLEOSTINE,N017588,Prescription,CORDEN PHARMA,CAPSULE (ORAL),100MG,LOMUSTINE,,,
17588,4,GLEOSTINE,N017588,Discontinued,CORDEN PHARMA,CAPSULE (ORAL),5MG,LOMUSTINE,,,
17604,2,NALFON,N017604,Discontinued,XSPIRE PHARMA,CAPSULE (ORAL),EQ 300MG BASE,FENOPROFEN CALCIUM,Medication Guide,2009-11-19T00:00:00Z,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088655.pdf
17604,3,NALFON,N017604,Prescription,XSPIRE PHARMA,CAPSULE (ORAL),EQ 200MG BASE,FENOPROFEN CALCIUM,Medication Guide,2009-11-19T00:00:00Z,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088655.pdf
17604,4,NALFON,N017604,Prescription,XSPIRE PHARMA,CAPSULE (ORAL),EQ 400MG BASE,FENOPROFEN CALCIUM,Medication Guide,2009-11-19T00:00:00Z,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088655.pdf
17609,1,NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER,N017609,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;30MG/100ML;37MG/100ML;222MG/100ML;526MG/100ML;502MG/100ML,DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,,,
17610,1,NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER,N017610,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;21MG/100ML;128MG/100ML;234MG/100ML,DEXTROSE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE,,,
17634,1,DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER,N017634,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML,DEXTROSE; POTASSIUM CHLORIDE,,,
17634,2,DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,N017634,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML,DEXTROSE; POTASSIUM CHLORIDE,,,
17634,3,DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER,N017634,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;224MG/100ML,DEXTROSE; POTASSIUM CHLORIDE,,,
17634,4,DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER,N017634,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML,DEXTROSE; POTASSIUM CHLORIDE,,,
17637,2,PHYSIOSOL IN PLASTIC CONTAINER,N017637,Prescription,ICU MEDICAL INC,SOLUTION (IRRIGATION),30MG/100ML;37MG/100ML;222MG/100ML;526MG/100ML;502MG/100ML,MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,,,
17744,1,MOTOFEN HALF-STRENGTH,N017744,Discontinued,SEBELA IRELAND LTD,TABLET (ORAL),0.025MG;0.5MG,ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE,,,
17744,2,MOTOFEN,N017744,Prescription,SEBELA IRELAND LTD,TABLET (ORAL),0.025MG;1MG,ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE,,,
17766,1,NEPHRAMINE 5.4%,N017766,Prescription,B BRAUN,INJECTABLE (INJECTION),5.4% (5.4GM/100ML),AMINO ACIDS,,,
17810,1,PROSTIN E2,N017810,Prescription,PFIZER,SUPPOSITORY (VAGINAL),20MG,DINOPROSTONE,,,
17824,1,HALOG,N017824,Prescription,SUN PHARM INDS INC,OINTMENT (TOPICAL),0.10%,HALCINONIDE,,,
17863,1,SORBITOL 3% IN PLASTIC CONTAINER,N017863,Prescription,BAXTER HLTHCARE,SOLUTION (IRRIGATION),3GM/100ML,SORBITOL,,,
18008,1,"DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER",N018008,Discontinued,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,2,"DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER",N018008,Discontinued,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,3,"DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER",N018008,Discontinued,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;224MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,4,POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N018008,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,5,POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N018008,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,6,POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N018008,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,7,POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N018008,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,8,POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N018008,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;224MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,9,POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N018008,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18008,10,"DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER",N018008,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18045,1,EMCYT,N018045,Prescription,PHARMACIA AND UPJOHN,CAPSULE (ORAL),EQ 140MG PHOSPHATE,ESTRAMUSTINE PHOSPHATE SODIUM,,,
18074,1,PHENDIMETRAZINE TARTRATE,N018074,Prescription,VIRTUS PHARMS,"CAPSULE, EXTENDED RELEASE (ORAL)",105MG,PHENDIMETRAZINE TARTRATE,,,
18279,1,K-TAB,N018279,Prescription,ABBVIE,"TABLET, EXTENDED RELEASE (ORAL)",10MEQ,POTASSIUM CHLORIDE,,,
18279,2,K-TAB,N018279,Prescription,ABBVIE,"TABLET, EXTENDED RELEASE (ORAL)",8MEQ,POTASSIUM CHLORIDE,,,
18279,3,K-TAB,N018279,Prescription,ABBVIE,"TABLET, EXTENDED RELEASE (ORAL)",20MEQ,POTASSIUM CHLORIDE,,,
18365,1,POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;149MG/100ML;225MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18365,2,POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18365,3,POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18365,4,POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18365,5,POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18365,6,POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18365,7,POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18365,8,POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18365,9,POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,N018365,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
18371,1,POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER,N018371,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;149MG/100ML,DEXTROSE; POTASSIUM CHLORIDE,,,
18371,2,POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER,N018371,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;298MG/100ML,DEXTROSE; POTASSIUM CHLORIDE,,,
18371,3,POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER,N018371,Discontinued,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;224MG/100ML,DEXTROSE; POTASSIUM CHLORIDE,,,
18469,1,BSS PLUS,N018469,Prescription,ALCON,SOLUTION (IRRIGATION),0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML,CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE,,,
18511,1,DRAXIMAGE DTPA,N018511,Prescription,JUBILANT,INJECTABLE (INJECTION),N/A,TECHNETIUM TC-99M PENTETATE KIT,,,
18562,1,DEXTROSE 40% IN PLASTIC CONTAINER,N018562,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),40GM/100ML,DEXTROSE,,,
18564,1,DEXTROSE 20% IN PLASTIC CONTAINER,N018564,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),20GM/100ML,DEXTROSE,,,
18582,1,PROCALAMINE,N018582,Prescription,B BRAUN,INJECTABLE (INJECTION),3%;26MG/100ML;3GM/100ML;54MG/100ML;41MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML,AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
18609,1,"HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER",N018609,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),200 UNITS/100ML,HEPARIN SODIUM,,,
18609,2,"HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER",N018609,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),200 UNITS/100ML,HEPARIN SODIUM,,,
18609,3,"HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER",N018609,Discontinued,BAXTER HLTHCARE,INJECTABLE (INJECTION),500 UNITS/100ML,HEPARIN SODIUM,,,
18609,4,"HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER",N018609,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),"2,000 UNITS/1000ML",HEPARIN SODIUM,,,
18634,1,BETADINE,N018634,Prescription,ALCON PHARMS LTD,SOLUTION/DROPS (OPHTHALMIC),5%,POVIDONE-IODINE,,,
18655,1,NORPACE CR,N018655,Prescription,PFIZER,"CAPSULE, EXTENDED RELEASE (ORAL)",EQ 100MG BASE,DISOPYRAMIDE PHOSPHATE,,,
18655,2,NORPACE CR,N018655,Prescription,PFIZER,"CAPSULE, EXTENDED RELEASE (ORAL)",EQ 150MG BASE,DISOPYRAMIDE PHOSPHATE,,,
18677,1,CESAMET,N018677,Prescription,BAUSCH,CAPSULE (ORAL),1MG,NABILONE,Review,2019-02-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/018677Orig1s000rev.pdf
18689,1,RIDAURA,N018689,Prescription,SEBELA IRELAND LTD,CAPSULE (ORAL),3MG,AURANOFIN,Review,2019-02-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/018689Orig1s000rev.pdf
18892,1,SODIUM PHOSPHATES IN PLASTIC CONTAINER,N018892,Prescription,HOSPIRA,INJECTABLE (INJECTION),142MG/ML;276MG/ML,"SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS",,,
18893,1,SODIUM ACETATE,N018893,Prescription,HOSPIRA,INJECTABLE (INJECTION),2MEQ/ML,SODIUM ACETATE,,,
18895,1,TPN ELECTROLYTES IN PLASTIC CONTAINER,N018895,Prescription,HOSPIRA,INJECTABLE (INJECTION),16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML;16.1MG/ML,CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE,,,
18897,1,SODIUM CHLORIDE 14.6%,N018897,Discontinued,HOSPIRA,SOLUTION (INTRAVENOUS),50MEQ/20ML (2.5MEQ/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,SODIUM CHLORIDE,,,
18897,2,SODIUM CHLORIDE 14.6%,N018897,Prescription,HOSPIRA,SOLUTION (INTRAVENOUS),100MEQ/40ML (2.5MEQ/ML),SODIUM CHLORIDE,,,
18897,3,SODIUM CHLORIDE 23.4%,N018897,Prescription,HOSPIRA,SOLUTION (INTRAVENOUS),400MEQ/100ML (4MEQ/ML),SODIUM CHLORIDE,,,
18916,1,"HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%",N018916,Discontinued,HOSPIRA,INJECTABLE (INJECTION),"1,000 UNITS/100ML",HEPARIN SODIUM,,,
18916,2,"HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%",N018916,Discontinued,HOSPIRA,INJECTABLE (INJECTION),"10,000 UNITS/100ML",HEPARIN SODIUM,,,
18916,3,"HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%",N018916,Discontinued,HOSPIRA,INJECTABLE (INJECTION),"5,000 UNITS/100ML",HEPARIN SODIUM,,,
18916,4,"HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%",N018916,Discontinued,HOSPIRA,INJECTABLE (INJECTION),100 UNITS/ML,HEPARIN SODIUM,,,
18916,5,"HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%",N018916,Discontinued,HOSPIRA,INJECTABLE (INJECTION),"10,000 UNITS/100ML",HEPARIN SODIUM,,,
18916,6,"HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER",N018916,Prescription,HOSPIRA,INJECTABLE (INJECTION),"5,000 UNITS/100ML",HEPARIN SODIUM,,,
18916,7,"HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER",N018916,Prescription,HOSPIRA,INJECTABLE (INJECTION),"5,000 UNITS/100ML",HEPARIN SODIUM,,,
18916,8,"HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER",N018916,Prescription,HOSPIRA,INJECTABLE (INJECTION),"10,000 UNITS/100ML",HEPARIN SODIUM,,,
18916,9,"HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER",N018916,Discontinued,HOSPIRA,INJECTABLE (INJECTION),"5,000 UNITS/100ML",HEPARIN SODIUM,,,
18916,10,"HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER",N018916,Prescription,HOSPIRA,INJECTABLE (INJECTION),200 UNITS/100ML,HEPARIN SODIUM,,,
18916,11,"HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER",N018916,Prescription,HOSPIRA,INJECTABLE (INJECTION),200 UNITS/100ML,HEPARIN SODIUM,,,
18920,1,M.V.I. PEDIATRIC,N018920,Prescription,HOSPIRA,FOR SOLUTION (INTRAVENOUS),80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL,ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E,,,
18931,1,TRAVASOL 5.5% IN PLASTIC CONTAINER,N018931,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5.5% (5.5GM/100ML),AMINO ACIDS,,,
18931,2,TRAVASOL 8.5% IN PLASTIC CONTAINER,N018931,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),8.5% (8.5GM/100ML),AMINO ACIDS,,,
18931,3,TRAVASOL 10% IN PLASTIC CONTAINER,N018931,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),10% (10MG/100ML),AMINO ACIDS,,,
18960,1,CUPRIC CHLORIDE IN PLASTIC CONTAINER,N018960,Prescription,HOSPIRA,INJECTABLE (INJECTION),EQ 0.4MG COPPER/ML,CUPRIC CHLORIDE,,,
18961,1,CHROMIC CHLORIDE IN PLASTIC CONTAINER,N018961,Prescription,HOSPIRA,INJECTABLE (INJECTION),EQ 0.004MG CHROMIUM/ML,CHROMIC CHLORIDE,,,
18962,1,MANGANESE CHLORIDE IN PLASTIC CONTAINER,N018962,Prescription,HOSPIRA,INJECTABLE (INJECTION),EQ 0.1MG MANGANESE/ML,MANGANESE CHLORIDE,,,
19024,1,PHYSIOLYTE IN PLASTIC CONTAINER,N019024,Prescription,B BRAUN,SOLUTION (IRRIGATION),30MG/100ML;37MG/100ML;370MG/100ML;530MG/100ML;500MG/100ML,MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,,,
19034,1,DILAUDID-HP,N019034,Discontinued,FRESENIUS KABI USA,INJECTABLE (INJECTION),10MG/ML,HYDROMORPHONE HYDROCHLORIDE,,,
19034,2,DILAUDID-HP,N019034,Discontinued,FRESENIUS KABI USA,INJECTABLE (INJECTION),250MG/VIAL,HYDROMORPHONE HYDROCHLORIDE,,,
19034,3,DILAUDID,N019034,Prescription,FRESENIUS KABI USA,INJECTABLE (INJECTION),1MG/ML,HYDROMORPHONE HYDROCHLORIDE,,,
19034,4,DILAUDID,N019034,Prescription,FRESENIUS KABI USA,INJECTABLE (INJECTION),2MG/ML,HYDROMORPHONE HYDROCHLORIDE,,,
19034,5,DILAUDID,N019034,Discontinued,FRESENIUS KABI USA,INJECTABLE (INJECTION),4MG/ML,HYDROMORPHONE HYDROCHLORIDE,,,
19034,6,DILAUDID,N019034,Prescription,FRESENIUS KABI USA,INJECTABLE (INJECTION),0.2MG/ML,HYDROMORPHONE HYDROCHLORIDE,,,
19099,1,DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER,N019099,Prescription,B BRAUN,INJECTABLE (INJECTION),40MG/100ML,DOPAMINE HYDROCHLORIDE,,,
19099,2,DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%,N019099,Prescription,B BRAUN,INJECTABLE (INJECTION),80MG/100ML,DOPAMINE HYDROCHLORIDE,,,
19099,3,DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER,N019099,Prescription,B BRAUN,INJECTABLE (INJECTION),160MG/100ML,DOPAMINE HYDROCHLORIDE,,,
19099,4,DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%,N019099,Prescription,B BRAUN,INJECTABLE (INJECTION),320MG/100ML,DOPAMINE HYDROCHLORIDE,,,
19193,1,PROVOCHOLINE,N019193,Prescription,METHAPHARM,FOR SOLUTION (INHALATION),100MG/VIAL,METHACHOLINE CHLORIDE,,,
19193,2,PROVOCHOLINE,N019193,Discontinued,METHAPHARM,FOR SOLUTION (INHALATION),1600MG/VIAL,METHACHOLINE CHLORIDE,,,
19261,1,PAREMYD,N019261,Prescription,AKORN,SOLUTION/DROPS (OPHTHALMIC),1%;0.25%,HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE,,,
19308,1,POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019308,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19308,2,POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019308,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19308,3,POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019308,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19308,4,POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019308,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19308,5,POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019308,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19308,6,POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019308,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;224MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19308,7,POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019308,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19316,1,MAGNESIUM SULFATE,N019316,Prescription,FRESENIUS KABI USA,"SOLUTION (INTRAMUSCULAR, INTRAVENOUS)",5GM/10ML (500MG/ML),MAGNESIUM SULFATE,,,
19316,2,MAGNESIUM SULFATE,N019316,Prescription,FRESENIUS KABI USA,"SOLUTION (INTRAMUSCULAR, INTRAVENOUS)",1GM/2ML (500MG/ML),MAGNESIUM SULFATE,,,
19316,3,MAGNESIUM SULFATE,N019316,Prescription,FRESENIUS KABI USA,"SOLUTION (INTRAMUSCULAR, INTRAVENOUS)",10GM/20ML (500MG/ML),MAGNESIUM SULFATE,,,
19316,4,MAGNESIUM SULFATE,N019316,Prescription,FRESENIUS KABI USA,"SOLUTION (INTRAMUSCULAR, INTRAVENOUS)",25GM/50ML (500MG/ML),MAGNESIUM SULFATE,,,
19319,2,SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER,N019319,Prescription,BAXTER HLTHCARE,SOLUTION FOR SLUSH (IRRIGATION),900MG/100ML,SODIUM CHLORIDE,,,
19339,1,"HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER",N019339,Prescription,HOSPIRA,INJECTABLE (INJECTION),"5,000 UNITS/100ML",HEPARIN SODIUM,,,
19339,2,"HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER",N019339,Prescription,HOSPIRA,INJECTABLE (INJECTION),"10,000 UNITS/100ML",HEPARIN SODIUM,,,
19339,3,"HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER",N019339,Prescription,HOSPIRA,INJECTABLE (INJECTION),"10,000 UNITS/100ML",HEPARIN SODIUM,,,
19339,4,"HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER",N019339,Prescription,HOSPIRA,INJECTABLE (INJECTION),"5,000 UNITS/100ML",HEPARIN SODIUM,,,
19345,1,DEXTROSE 30% IN PLASTIC CONTAINER,N019345,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),30GM/100ML,DEXTROSE,,,
19357,1,ETHAMOLIN,N019357,Prescription,QOL MEDCL,INJECTABLE (INJECTION),50MG/ML,ETHANOLAMINE OLEATE,,,
19367,1,POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,N019367,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;105MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19367,2,POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,N019367,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;105MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19367,3,POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,N019367,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19367,4,POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,N019367,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19367,5,POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,N019367,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;328MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19367,6,POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,N019367,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;254MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19367,7,POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,N019367,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;254MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19367,8,POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,N019367,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;328MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19398,1,AMINOSYN-PF 7%,N019398,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),7% (7GM/100ML),AMINO ACIDS,,,
19445,1,DEXTROSE 50%,N019445,Prescription,HOSPIRA,INJECTABLE (INJECTION),500MG/ML,DEXTROSE,,,
19445,2,DEXTROSE 25%,N019445,Prescription,HOSPIRA,INJECTABLE (INJECTION),250MG/ML,DEXTROSE,,,
19463,1,TIMOPTIC IN OCUDOSE,N019463,Prescription,VALEANT PHARMS INTL,SOLUTION/DROPS (OPHTHALMIC),EQ 0.25% BASE,TIMOLOL MALEATE,,,
19463,2,TIMOPTIC IN OCUDOSE,N019463,Prescription,VALEANT PHARMS INTL,SOLUTION/DROPS (OPHTHALMIC),EQ 0.5% BASE,TIMOLOL MALEATE,,,
19481,1,RENACIDIN,N019481,Prescription,UNITED GUARDIAN,SOLUTION (IRRIGATION),6.602GM/100ML;198MG/100ML;3.177GM/100ML,CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE,,,
19513,1,IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER,N019513,Prescription,ICU MEDICAL INC,INJECTABLE (INJECTION),5GM/100ML;30MG/100ML;141MG/100ML;15MG/100ML;260MG/100ML;25MG/100ML,"DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS",,,
19614,1,VERELAN,N019614,Prescription,RECRO GAINESVILLE,"CAPSULE, EXTENDED RELEASE (ORAL)",120MG,VERAPAMIL HYDROCHLORIDE,,,
19614,2,VERELAN,N019614,Prescription,RECRO GAINESVILLE,"CAPSULE, EXTENDED RELEASE (ORAL)",240MG,VERAPAMIL HYDROCHLORIDE,,,
19614,3,VERELAN,N019614,Prescription,RECRO GAINESVILLE,"CAPSULE, EXTENDED RELEASE (ORAL)",180MG,VERAPAMIL HYDROCHLORIDE,,,
19614,4,VERELAN,N019614,Prescription,RECRO GAINESVILLE,"CAPSULE, EXTENDED RELEASE (ORAL)",360MG,VERAPAMIL HYDROCHLORIDE,,,
19615,1,DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER,N019615,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),80MG/100ML,DOPAMINE HYDROCHLORIDE,,,
19615,2,DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER,N019615,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),160MG/100ML,DOPAMINE HYDROCHLORIDE,,,
19615,3,DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER,N019615,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),320MG/100ML,DOPAMINE HYDROCHLORIDE,,,
19615,4,DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER,N019615,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),640MG/100ML,DOPAMINE HYDROCHLORIDE,,,
19617,1,PREPIDIL,N019617,Prescription,PFIZER,GEL (ENDOCERVICAL),0.5MG/3GM,DINOPROSTONE,,,
19630,1,POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;37MG/100ML;110MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,2,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML;110MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,3,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;110MG/100ML;110MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,4,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;110MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,5,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;220MG/100ML;110MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,6,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;110MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,7,POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;37MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,8,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,9,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;110MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,10,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,11,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;220MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,12,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,13,POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;37MG/100ML;330MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,14,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML;330MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,15,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;110MG/100ML;330MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,16,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;330MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,17,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;220MG/100ML;330MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,18,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;330MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,19,POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;37MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,20,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,21,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;110MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,22,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,23,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;220MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,24,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,25,POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;37MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,26,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;75MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,27,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;110MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,28,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;150MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,29,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;220MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,30,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;300MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,31,POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;37MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,32,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;75MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,33,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;110MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,34,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;150MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,35,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;220MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,36,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;300MG/100ML;200MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,37,POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;37MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,38,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;75MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,39,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;110MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,40,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;150MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,41,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;220MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,42,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;300MG/100ML;450MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,43,POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;37MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,44,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;75MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,45,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;110MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,46,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;150MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,47,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;220MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,48,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;300MG/100ML;900MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,49,POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),3.3GM/100ML;75MG/100ML;300MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,50,POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),3.3GM/100ML;110MG/100ML;300MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,51,POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),3.3GM/100ML;150MG/100ML;300MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,52,POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),3.3GM/100ML;220MG/100ML;300MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19630,53,POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,N019630,Prescription,B BRAUN,INJECTABLE (INJECTION),3.3GM/100ML;300MG/100ML;300MG/100ML,DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,,,
19631,1,DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),2.5GM/100ML;110MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,2,DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),2.5GM/100ML;200MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,3,DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),2.5GM/100ML;330MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,4,DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),2.5GM/100ML;450MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,5,DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),2.5GM/100ML;900MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,6,DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;110MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,7,DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;200MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,8,DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;330MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,9,DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;450MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,10,DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;900MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,11,DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;110MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,12,DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;200MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,13,DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;330MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,14,DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;450MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,15,DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),10GM/100ML;900MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19631,16,DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,N019631,Prescription,B BRAUN,INJECTABLE (INJECTION),3.3GM/100ML;300MG/100ML,DEXTROSE; SODIUM CHLORIDE,,,
19634,1,DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER,N019634,Prescription,B BRAUN,INJECTABLE (INJECTION),10MG/100ML;2.5GM/100ML;15MG/100ML;300MG/100ML;160MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19634,2,DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER,N019634,Discontinued,B BRAUN,INJECTABLE (INJECTION),4MG/100ML;4GM/100ML;6MG/100ML;120MG/100ML;62MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19634,3,DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER,N019634,Prescription,B BRAUN,INJECTABLE (INJECTION),20MG/100ML;5GM/100ML;30MG/100ML;600MG/100ML;310MG/100ML,CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,,,
19635,1,SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,N019635,Prescription,B BRAUN,INJECTABLE (INJECTION),450MG/100ML,SODIUM CHLORIDE,,,
19635,2,SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N019635,Prescription,B BRAUN,INJECTABLE (INJECTION),900MG/100ML,SODIUM CHLORIDE,,,
19635,3,SODIUM CHLORIDE 3% IN PLASTIC CONTAINER,N019635,Prescription,B BRAUN,INJECTABLE (INJECTION),3GM/100ML,SODIUM CHLORIDE,,,
19635,4,SODIUM CHLORIDE 5% IN PLASTIC CONTAINER,N019635,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML,SODIUM CHLORIDE,,,
19635,5,SODIUM CHLORIDE 0.9%,N019635,Prescription,B BRAUN,INJECTABLE (INJECTION),9MG/10ML,SODIUM CHLORIDE,,,
19696,1,ISOLYTE S PH 7.4 IN PLASTIC CONTAINER,N019696,Prescription,B BRAUN,INJECTABLE (INJECTION),30MG/100ML;37MG/100ML;0.82MG/100ML;370MG/100ML;530MG/100ML;500MG/100ML;12MG/100ML,"MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE",,,
19711,1,ISOLYTE S IN PLASTIC CONTAINER,N019711,Prescription,B BRAUN,INJECTABLE (INJECTION),30MG/100ML;37MG/100ML;370MG/100ML;530MG/100ML;500MG/100ML,MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,,,
19715,1,DIPENTUM,N019715,Prescription,MYLAN SPECIALITY LP,CAPSULE (ORAL),250MG,OLSALAZINE SODIUM,,,
19732,1,LUPRON DEPOT,N019732,Prescription,ABBVIE ENDOCRINE INC,INJECTABLE (INJECTION),7.5MG/VIAL,LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
19779,1,IOPIDINE,N019779,Prescription,NOVARTIS,SOLUTION/DROPS (OPHTHALMIC),EQ 1% BASE,APRACLONIDINE HYDROCHLORIDE,,,
19826,1,THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER,N019826,Prescription,B BRAUN,INJECTABLE (INJECTION),40MG/100ML,THEOPHYLLINE,,,
19826,2,THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER,N019826,Prescription,B BRAUN,INJECTABLE (INJECTION),80MG/100ML,THEOPHYLLINE,,,
19826,3,THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER,N019826,Prescription,B BRAUN,INJECTABLE (INJECTION),160MG/100ML,THEOPHYLLINE,,,
19826,4,THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER,N019826,Discontinued,B BRAUN,INJECTABLE (INJECTION),200MG/100ML,THEOPHYLLINE,,,
19826,5,THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER,N019826,Discontinued,B BRAUN,INJECTABLE (INJECTION),400MG/100ML,THEOPHYLLINE,,,
19826,6,THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER,N019826,Prescription,B BRAUN,INJECTABLE (INJECTION),320MG/100ML,THEOPHYLLINE,,,
19829,1,CERETEC,N019829,Prescription,GE HEALTHCARE,INJECTABLE (INJECTION),N/A,TECHNETIUM TC-99M EXAMETAZIME KIT,,,
19845,1,BETOPTIC S,N019845,Prescription,NOVARTIS,SUSPENSION/DROPS (OPHTHALMIC),EQ 0.25% BASE,BETAXOLOL HYDROCHLORIDE,,,
19873,1,ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER,N019873,Prescription,B BRAUN,INJECTABLE (INJECTION),5GM/100ML;31MG/100ML;130MG/100ML;26MG/100ML;320MG/100ML,"DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE",,,
19904,1,POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER,N019904,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),14.9MG/ML,POTASSIUM CHLORIDE,,,
19904,2,POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER,N019904,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),29.8MG/ML,POTASSIUM CHLORIDE,,,
19904,3,POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER,N019904,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),2.24GM/100ML,POTASSIUM CHLORIDE,,,
19904,4,POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER,N019904,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),2.98GM/100ML,POTASSIUM CHLORIDE,,,
19904,5,POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER,N019904,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),746MG/100ML,POTASSIUM CHLORIDE,,,
19904,6,POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER,N019904,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),1.49GM/100ML,POTASSIUM CHLORIDE,,,
19998,2,CHEMET,N019998,Prescription,RECORDATI RARE,CAPSULE (ORAL),100MG,SUCCIMER,,,
20011,1,LUPRON DEPOT,N020011,Discontinued,ABBVIE ENDOCRINE INC,INJECTABLE (INJECTION),3.75MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20011,2,LUPRON DEPOT,N020011,Prescription,ABBVIE ENDOCRINE INC,INJECTABLE (INJECTION),3.75MG,LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20049,1,PENTASA,N020049,Prescription,TAKEDA PHARMS USA,"CAPSULE, EXTENDED RELEASE (ORAL)",250MG,MESALAMINE,Review,1998-02-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/020049a_052292_biopharmrev.pdf
20049,2,PENTASA,N020049,Prescription,TAKEDA PHARMS USA,"CAPSULE, EXTENDED RELEASE (ORAL)",500MG,MESALAMINE,Review,1998-02-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/020049a_052292_biopharmrev.pdf
20126,1,ZONALON,N020126,Prescription,MYLAN,CREAM (TOPICAL),5%,DOXEPIN HYDROCHLORIDE,,,
20145,1,NITRO-DUR,N020145,Prescription,USPHARMA,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.1MG/HR,NITROGLYCERIN,,,
20145,2,NITRO-DUR,N020145,Prescription,USPHARMA,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.2MG/HR,NITROGLYCERIN,,,
20145,3,NITRO-DUR,N020145,Prescription,USPHARMA,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.3MG/HR,NITROGLYCERIN,,,
20145,4,NITRO-DUR,N020145,Prescription,USPHARMA,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.4MG/HR,NITROGLYCERIN,,,
20145,5,NITRO-DUR,N020145,Prescription,USPHARMA,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.6MG/HR,NITROGLYCERIN,,,
20145,6,NITRO-DUR,N020145,Prescription,USPHARMA,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.8MG/HR,NITROGLYCERIN,,,
20191,1,ALOMIDE,N020191,Prescription,NOVARTIS,SOLUTION/DROPS (OPHTHALMIC),EQ 0.1% BASE,LODOXAMIDE TROMETHAMINE,,,
20193,1,ELMIRON,N020193,Prescription,JANSSEN PHARMS,CAPSULE (ORAL),100MG,PENTOSAN POLYSULFATE SODIUM,Review,2019-02-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020193Orig1s000rev.pdf
20209,1,OXISTAT,N020209,Prescription,ANI PHARMS,LOTION (TOPICAL),EQ 1% BASE,OXICONAZOLE NITRATE,,,
20213,1,MIOCHOL-E,N020213,Prescription,BAUSCH AND LOMB,FOR SOLUTION (OPHTHALMIC),20MG/VIAL,ACETYLCHOLINE CHLORIDE,,,
20263,2,LUPRON DEPOT-PED KIT,N020263,Prescription,ABBVIE ENDOCRINE INC,POWDER (INTRAMUSCULAR),7.5MG,LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20263,3,LUPRON DEPOT-PED KIT,N020263,Discontinued,ABBVIE ENDOCRINE INC,POWDER (INTRAMUSCULAR),"3.75MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**",LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20263,4,LUPRON DEPOT-PED KIT,N020263,Discontinued,ABBVIE ENDOCRINE INC,POWDER (INTRAMUSCULAR),"7.5MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**",LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20263,5,LUPRON DEPOT-PED KIT,N020263,Prescription,ABBVIE ENDOCRINE INC,POWDER (INTRAMUSCULAR),11.25MG,LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20263,6,LUPRON DEPOT-PED KIT,N020263,Prescription,ABBVIE ENDOCRINE INC,POWDER (INTRAMUSCULAR),15MG,LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20263,7,LUPRON DEPOT-PED KIT,N020263,Prescription,ABBVIE ENDOCRINE INC,POWDER (INTRAMUSCULAR),11.25MG,LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20263,8,LUPRON DEPOT-PED KIT,N020263,Prescription,ABBVIE ENDOCRINE INC,POWDER (INTRAMUSCULAR),30MG,LEUPROLIDE ACETATE,Other Important Information from FDA,2011-12-20T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm209848.htm
20351,1,VISIPAQUE 270,N020351,Prescription,GE HEALTHCARE,INJECTABLE (INJECTION),55%,IODIXANOL,,,
20351,2,VISIPAQUE 320,N020351,Prescription,GE HEALTHCARE,INJECTABLE (INJECTION),65.20%,IODIXANOL,,,
20369,1,CILOXAN,N020369,Prescription,NOVARTIS,OINTMENT (OPHTHALMIC),EQ 0.3% BASE,CIPROFLOXACIN HYDROCHLORIDE,Letter,1998-03-30T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20369ltr.pdf
20385,1,NICOTROL,N020385,Prescription,PFIZER INC,"SPRAY, METERED (NASAL)",0.5MG/SPRAY,NICOTINE,,,
20405,1,LANOXIN,N020405,Prescription,CONCORDIA,TABLET (ORAL),0.0625MG,DIGOXIN,Review,2010-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020405_lanoxin_toc.cfm
20405,2,LANOXIN,N020405,Prescription,CONCORDIA,TABLET (ORAL),0.125MG,DIGOXIN,Review,2010-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020405_lanoxin_toc.cfm
20405,3,LANOXIN,N020405,Discontinued,CONCORDIA,TABLET (ORAL),0.1875MG,DIGOXIN,Review,2010-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020405_lanoxin_toc.cfm
20405,4,LANOXIN,N020405,Prescription,CONCORDIA,TABLET (ORAL),0.25MG,DIGOXIN,Review,2010-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020405_lanoxin_toc.cfm
20405,5,LANOXIN,N020405,Discontinued,CONCORDIA,TABLET (ORAL),0.375MG,DIGOXIN,Review,2010-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020405_lanoxin_toc.cfm
20405,6,LANOXIN,N020405,Discontinued,CONCORDIA,TABLET (ORAL),0.5MG,DIGOXIN,Review,2010-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020405_lanoxin_toc.cfm
20411,1,CERVIDIL,N020411,Prescription,FERRING PHARMS INC,"INSERT, EXTENDED RELEASE (VAGINAL)",10MG,DINOPROSTONE,,,
20428,1,AZELEX,N020428,Prescription,ALMIRALL,CREAM (TOPICAL),20%,AZELAIC ACID,Review,2019-02-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020428Orig1s000rev.pdf
20457,1,ETOPOPHOS PRESERVATIVE FREE,N020457,Prescription,CHEPLAPHARM,INJECTABLE (INJECTION),EQ 100MG BASE/VIAL,ETOPOSIDE PHOSPHATE,,,
20471,1,ZYFLO,N020471,Discontinued,CHIESI,TABLET (ORAL),300MG,ZILEUTON,Review,1997-02-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020471Orig1s000rev.pdf
20471,3,ZYFLO,N020471,Prescription,CHIESI,TABLET (ORAL),600MG,ZILEUTON,Review,1997-02-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020471Orig1s000rev.pdf
20475,1,RETIN-A MICRO,N020475,Prescription,VALEANT INTL,GEL (TOPICAL),0.10%,TRETINOIN,Review,1997-02-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020475ap.pdf
20475,2,RETIN-A MICRO,N020475,Prescription,VALEANT INTL,GEL (TOPICAL),0.04%,TRETINOIN,Review,1997-02-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020475ap.pdf
20475,3,RETIN-A-MICRO,N020475,Prescription,VALEANT INTL,GEL (TOPICAL),0.08%,TRETINOIN,Review,1997-02-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020475ap.pdf
20475,4,RETIN-A-MICRO,N020475,Prescription,VALEANT INTL,GEL (TOPICAL),0.06%,TRETINOIN,Review,1997-02-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020475ap.pdf
20488,1,MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER,N020488,Prescription,HOSPIRA,INJECTABLE (INJECTION),1GM/100ML,MAGNESIUM SULFATE,Review,1995-07-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020488_original_approval.pdf
20488,2,MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER,N020488,Prescription,HOSPIRA,INJECTABLE (INJECTION),2GM/100ML,MAGNESIUM SULFATE,Review,1995-07-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020488_original_approval.pdf
20489,1,ANDRODERM,N020489,Discontinued,ALLERGAN,"FILM, EXTENDED RELEASE (TRANSDERMAL)",2.5MG/24HR,TESTOSTERONE,,,
20489,2,ANDRODERM,N020489,Discontinued,ALLERGAN,"FILM, EXTENDED RELEASE (TRANSDERMAL)",5MG/24HR,TESTOSTERONE,,,
20489,3,ANDRODERM,N020489,Prescription,ALLERGAN,"FILM, EXTENDED RELEASE (TRANSDERMAL)",2MG/24HR,TESTOSTERONE,,,
20489,4,ANDRODERM,N020489,Prescription,ALLERGAN,"FILM, EXTENDED RELEASE (TRANSDERMAL)",4MG/24HR,TESTOSTERONE,,,
20517,1,LUPRON DEPOT,N020517,Prescription,ABBVIE ENDOCRINE INC,INJECTABLE (INJECTION),22.5MG/VIAL,LEUPROLIDE ACETATE,Review,2006-04-06T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020517_S000_Lupron_Depot.PDF
20517,2,LUPRON DEPOT,N020517,Prescription,ABBVIE ENDOCRINE INC,INJECTABLE (INJECTION),30MG/VIAL,LEUPROLIDE ACETATE,Review,2006-04-06T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020517_S000_Lupron_Depot.PDF
20517,3,LUPRON DEPOT,N020517,Prescription,ABBVIE ENDOCRINE INC,INJECTABLE (INJECTION),45MG/VIAL,LEUPROLIDE ACETATE,Review,2006-04-06T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020517_S000_Lupron_Depot.PDF
20524,1,MENTAX,N020524,Prescription,MYLAN,CREAM (TOPICAL),1%,BUTENAFINE HYDROCHLORIDE,Review,2019-02-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020524Orig1s000rev.pdf
20529,1,CONDYLOX,N020529,Prescription,ALLERGAN,GEL (TOPICAL),0.50%,PODOFILOX,Label,2018-12-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1997/020529s000lbl.pdf
20576,1,CYSTADANE,N020576,Prescription,ORPHAN EUROPE,FOR SOLUTION (ORAL),1GM/SCOOPFUL,BETAINE,Review,2019-02-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020576Orig1s000rev.pdf
20577,1,ELLIOTTS B SOLUTION,N020577,Prescription,LUKARE MEDICAL LLC,INJECTABLE (INTRATHECAL),0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML,"CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE",,,
20600,1,TAZORAC,N020600,Prescription,ALLERGAN,GEL (TOPICAL),0.05%,TAZAROTENE,Review,2003-08-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020600_tazorac_toc.cfm
20600,2,TAZORAC,N020600,Prescription,ALLERGAN,GEL (TOPICAL),0.10%,TAZAROTENE,Review,2003-08-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020600_tazorac_toc.cfm
20616,1,KADIAN,N020616,Prescription,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",20MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,2,KADIAN,N020616,Prescription,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",50MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,3,KADIAN,N020616,Prescription,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",100MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,4,KADIAN,N020616,Prescription,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",30MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,5,KADIAN,N020616,Prescription,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",60MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,6,KADIAN,N020616,Prescription,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",80MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,7,KADIAN,N020616,Discontinued,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",200MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,8,KADIAN,N020616,Prescription,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",10MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,9,KADIAN,N020616,Discontinued,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",40MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,10,KADIAN,N020616,Discontinued,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",70MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,11,KADIAN,N020616,Discontinued,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",130MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20616,12,KADIAN,N020616,Discontinued,ALLERGAN,"CAPSULE, EXTENDED RELEASE (ORAL)",150MG,MORPHINE SULFATE,Other,2012-07-11T00:00:00Z,http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
20629,1,DENAVIR,N020629,Prescription,MYLAN,CREAM (TOPICAL),1%,PENCICLOVIR,Review,2019-02-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020629Orig1s000rev.pdf
20648,1,DIASTAT,N020648,Prescription,BAUSCH,GEL (RECTAL),2.5MG/0.5ML (5MG/ML),DIAZEPAM,Other Important Information from FDA,2006-03-31T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm115425.htm
20648,2,DIASTAT,N020648,Discontinued,BAUSCH,GEL (RECTAL),5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DIAZEPAM,Other Important Information from FDA,2006-03-31T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm115425.htm
20648,3,DIASTAT,N020648,Discontinued,BAUSCH,GEL (RECTAL),10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DIAZEPAM,Other Important Information from FDA,2006-03-31T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm115425.htm
20648,4,DIASTAT,N020648,Discontinued,BAUSCH,GEL (RECTAL),15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DIAZEPAM,Other Important Information from FDA,2006-03-31T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm115425.htm
20648,5,DIASTAT,N020648,Discontinued,BAUSCH,GEL (RECTAL),20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,DIAZEPAM,Other Important Information from FDA,2006-03-31T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm115425.htm
20648,6,DIASTAT ACUDIAL,N020648,Prescription,BAUSCH,GEL (RECTAL),20MG/4ML (5MG/ML),DIAZEPAM,Other Important Information from FDA,2006-03-31T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm115425.htm
20648,7,DIASTAT ACUDIAL,N020648,Prescription,BAUSCH,GEL (RECTAL),10MG/2ML (5MG/ML),DIAZEPAM,Other Important Information from FDA,2006-03-31T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm115425.htm
20659,1,NORVIR,N020659,Prescription,ABBVIE,SOLUTION (ORAL),80MG/ML,RITONAVIR,Review,1997-04-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020659Orig1s000rev.pdf
20678,1,CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),2.75%;33MG/100ML;5GM/100ML;51MG/100ML;261MG/100ML;217MG/100ML;112MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,2,CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),2.75%;33MG/100ML;10GM/100ML;51MG/100ML;261MG/100ML;217MG/100ML;112MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,5,CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),2.75%;33MG/100ML;25GM/100ML;51MG/100ML;261MG/100ML;217MG/100ML;112MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,8,CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),4.25%;33MG/100ML;5GM/100ML;51MG/100ML;261MG/100ML;297MG/100ML;77MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,9,CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),4.25%;33MG/100ML;10GM/100ML;51MG/100ML;261MG/100ML;297MG/100ML;77MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,11,CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),4.25%;33MG/100ML;20GM/100ML;51MG/100ML;261MG/100ML;297MG/100ML;77MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,12,CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),4.25%;33MG/100ML;25GM/100ML;51MG/100ML;261MG/100ML;297MG/100ML;77MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,16,CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;33MG/100ML;10GM/100ML;51MG/100ML;261MG/100ML;340MG/100ML;59MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,17,CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;33MG/100ML;15GM/100ML;51MG/100ML;261MG/100ML;340MG/100ML;59MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,18,CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;33MG/100ML;20GM/100ML;51MG/100ML;261MG/100ML;340MG/100ML;59MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,19,CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;33MG/100ML;25GM/100ML;51MG/100ML;261MG/100ML;340MG/100ML;59MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20678,21,CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER,N020678,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;33MG/100ML;35GM/100ML;51MG/100ML;261MG/100ML;340MG/100ML;59MG/100ML,"AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE",Review,2010-01-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020678ap.pdf
20700,1,MUSE,N020700,Prescription,MYLAN SPECIALITY LP,SUPPOSITORY (URETHRAL),0.125MG,ALPROSTADIL,,,
20700,2,MUSE,N020700,Prescription,MYLAN SPECIALITY LP,SUPPOSITORY (URETHRAL),0.25MG,ALPROSTADIL,,,
20700,3,MUSE,N020700,Prescription,MYLAN SPECIALITY LP,SUPPOSITORY (URETHRAL),0.5MG,ALPROSTADIL,,,
20700,4,MUSE,N020700,Prescription,MYLAN SPECIALITY LP,SUPPOSITORY (URETHRAL),1MG,ALPROSTADIL,,,
20701,1,CRINONE,N020701,Prescription,ALLERGAN,GEL (VAGINAL),4%,PROGESTERONE,Review,2003-08-08T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020701_crinone_toc.cfm
20701,2,CRINONE,N020701,Prescription,ALLERGAN,GEL (VAGINAL),8%,PROGESTERONE,Review,2003-08-08T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020701_crinone_toc.cfm
20708,1,LUPRON DEPOT,N020708,Prescription,ABBVIE ENDOCRINE INC,INJECTABLE (INJECTION),11.25MG/VIAL,LEUPROLIDE ACETATE,Review,2003-08-08T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020708_lupron_toc.cfm
20715,1,TRELSTAR,N020715,Prescription,VERITY,INJECTABLE (INTRAMUSCULAR),EQ 3.75MG BASE/VIAL,TRIPTORELIN PAMOATE,Letter,2000-06-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20715ltr.pdf
20727,1,BIDIL,N020727,Prescription,ARBOR PHARMS LLC,TABLET (ORAL),37.5MG;20MG,HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE,Letter,2005-06-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020727ltr.pdf
20734,1,CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),2.75%;5GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,2,CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),2.75%;10GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,5,CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),2.75%;25GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,7,CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),4.25%;5GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,8,CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),4.25%;10GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,10,CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),4.25%;20GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,11,CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),4.25%;25GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,14,CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;10GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,15,CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;15GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,16,CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;20GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,17,CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;25GM/100ML,AMINO ACIDS; DEXTROSE,,,
20734,18,CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER,N020734,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),5%;35GM/100ML,AMINO ACIDS; DEXTROSE,,,
20743,1,NORITATE,N020743,Prescription,VALEANT PHARMS NORTH,CREAM (TOPICAL),1%,METRONIDAZOLE,Review,2003-08-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020743_noritate_toc.cfm
20766,1,XENICAL,N020766,Prescription,CHEPLAPHARM,CAPSULE (ORAL),120MG,ORLISTAT,Label,1999-04-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20766lbl.pdf
20779,1,VIRACEPT,N020779,Prescription,AGOURON PHARMS,TABLET (ORAL),EQ 250MG BASE,NELFINAVIR MESYLATE,Review,1997-03-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020779ap.pdf
20785,1,THALOMID,N020785,Prescription,CELGENE,CAPSULE (ORAL),50MG,THALIDOMIDE,Letter,1998-07-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20785ltr.pdf
20785,2,THALOMID,N020785,Prescription,CELGENE,CAPSULE (ORAL),100MG,THALIDOMIDE,Letter,1998-07-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20785ltr.pdf
20785,3,THALOMID,N020785,Prescription,CELGENE,CAPSULE (ORAL),200MG,THALIDOMIDE,Letter,1998-07-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20785ltr.pdf
20785,4,THALOMID,N020785,Prescription,CELGENE,CAPSULE (ORAL),150MG,THALIDOMIDE,Letter,1998-07-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20785ltr.pdf
20803,1,ALREX,N020803,Prescription,BAUSCH AND LOMB,SUSPENSION/DROPS (OPHTHALMIC),0.20%,LOTEPREDNOL ETABONATE,Label,1998-03-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20803lbl.pdf
20805,1,CIPRO HC,N020805,Prescription,NOVARTIS,SUSPENSION/DROPS (OTIC),EQ 0.2% BASE;1%,CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE,Letter,1998-02-10T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20805-mr.pdf
20849,1,PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER,N020849,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),20% (20GM/100ML),AMINO ACIDS,Label,1998-08-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20849lbl.pdf
20855,1,MESNEX,N020855,Prescription,BAXTER HLTHCARE,TABLET (ORAL),400MG,MESNA,Review,2003-05-08T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020855_mesnex.cfm
20870,1,COMBIPATCH,N020870,Prescription,NOVEN PHARMS INC,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.05MG/24HR;0.14MG/24HR,ESTRADIOL; NORETHINDRONE ACETATE,Label,1998-08-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20870lbl.pdf
20870,2,COMBIPATCH,N020870,Prescription,NOVEN PHARMS INC,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.05MG/24HR;0.25MG/24HR,ESTRADIOL; NORETHINDRONE ACETATE,Label,1998-08-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20870lbl.pdf
20905,1,ARAVA,N020905,Prescription,SANOFI AVENTIS US,TABLET (ORAL),10MG,LEFLUNOMIDE,Pediatric Written Request,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/020905_leflunomide_Arava_WR.pdf
20905,2,ARAVA,N020905,Prescription,SANOFI AVENTIS US,TABLET (ORAL),20MG,LEFLUNOMIDE,Pediatric Written Request,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/020905_leflunomide_Arava_WR.pdf
20905,3,ARAVA,N020905,Prescription,SANOFI AVENTIS US,TABLET (ORAL),100MG,LEFLUNOMIDE,Pediatric Written Request,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/020905_leflunomide_Arava_WR.pdf
21004,1,EPIVIR-HBV,N021004,Prescription,GLAXOSMITHKLINE,SOLUTION (ORAL),5MG/ML,LAMIVUDINE,Letter,1998-12-08T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/21003_Epivir-HBV_Approv.pdf
21008,1,SANDOSTATIN LAR,N021008,Prescription,NOVARTIS,INJECTABLE (INJECTION),EQ 10MG BASE/VIAL,OCTREOTIDE ACETATE,Label,1998-11-25T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21008lbl.pdf
21008,2,SANDOSTATIN LAR,N021008,Prescription,NOVARTIS,INJECTABLE (INJECTION),EQ 20MG BASE/VIAL,OCTREOTIDE ACETATE,Label,1998-11-25T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21008lbl.pdf
21008,3,SANDOSTATIN LAR,N021008,Prescription,NOVARTIS,INJECTABLE (INJECTION),EQ 30MG BASE/VIAL,OCTREOTIDE ACETATE,Label,1998-11-25T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21008lbl.pdf
21024,1,PRIFTIN,N021024,Prescription,SANOFI AVENTIS US,TABLET (ORAL),150MG,RIFAPENTINE,Letter,1998-06-22T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/21024ltr.pdf
21038,1,PRECEDEX,N021038,Prescription,HOSPIRA,INJECTABLE (INJECTION),EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Pediatric Written Request,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/21038_dexmedetomidine_Original_WR.pdf
21038,2,PRECEDEX,N021038,Prescription,HOSPIRA,INJECTABLE (INJECTION),EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Pediatric Written Request,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/21038_dexmedetomidine_Original_WR.pdf
21038,3,PRECEDEX,N021038,Prescription,HOSPIRA,INJECTABLE (INJECTION),EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Pediatric Written Request,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/21038_dexmedetomidine_Original_WR.pdf
21038,4,PRECEDEX,N021038,Prescription,HOSPIRA,INJECTABLE (INJECTION),EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Pediatric Written Request,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/21038_dexmedetomidine_Original_WR.pdf
21038,5,PRECEDEX,N021038,Prescription,HOSPIRA,INJECTABLE (INJECTION),EQ 1MG BASE/250ML (EQ 4MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Pediatric Written Request,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/21038_dexmedetomidine_Original_WR.pdf
21056,1,TARGRETIN,N021056,Prescription,BAUSCH,GEL (TOPICAL),1%,BEXAROTENE,Letter,2000-06-28T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21056ltr.pdf
21067,1,ASMANEX TWISTHALER,N021067,Prescription,ORGANON,POWDER (INHALATION),0.22MG/INH,MOMETASONE FUROATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021067s003_Mometasone_Clinical_PREA.pdf
21067,2,ASMANEX TWISTHALER,N021067,Prescription,ORGANON,POWDER (INHALATION),0.11MG/INH,MOMETASONE FUROATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021067s003_Mometasone_Clinical_PREA.pdf
21108,1,RENOVA,N021108,Prescription,VALEANT PHARMS NORTH,CREAM (TOPICAL),0.02%,TRETINOIN,Letter,2000-08-31T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21108LTr.PDF
21119,1,VISUDYNE,N021119,Prescription,VALEANT LUXEMBOURG,INJECTABLE (INJECTION),15MG/VIAL,VERTEPORFIN,Letter,2000-04-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21119ltr.pdf
21145,1,VANIQA,N021145,Prescription,SKINMEDICA,CREAM (TOPICAL),13.90%,EFLORNITHINE HYDROCHLORIDE,Label,2000-07-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21145lbl.pdf
21146,1,ATROPINE SULFATE,N021146,Discontinued,HOSPIRA,SOLUTION (INTRAVENOUS),0.5MG/5ML (0.1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,ATROPINE SULFATE,Label,2001-07-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine%20Sulfate_prntlbl.pdf
21146,2,ATROPINE SULFATE,N021146,Prescription,HOSPIRA,SOLUTION (INTRAVENOUS),0.25MG/5ML (0.05MG/ML),ATROPINE SULFATE,Label,2001-07-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine%20Sulfate_prntlbl.pdf
21146,3,ATROPINE SULFATE,N021146,Prescription,HOSPIRA,SOLUTION (INTRAVENOUS),1MG/10ML (0.1MG/ML),ATROPINE SULFATE,Label,2001-07-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine%20Sulfate_prntlbl.pdf
21146,4,ATROPINE SULFATE,N021146,Prescription,HOSPIRA,SOLUTION (INTRAVENOUS),0.5MG/5ML (0.1MG/ML),ATROPINE SULFATE,Label,2001-07-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine%20Sulfate_prntlbl.pdf
21146,5,ATROPINE SULFATE,N021146,Prescription,HOSPIRA,SOLUTION (INTRAVENOUS),1MG/10ML (0.1MG/ML),ATROPINE SULFATE,Label,2001-07-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine%20Sulfate_prntlbl.pdf
21163,1,INFUVITE ADULT,N021163,Prescription,SANDOZ CANADA INC,SOLUTION (INTRAVENOUS),2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML,ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K,Label,2000-05-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21163lbl.pdf
21163,2,INFUVITE ADULT,N021163,Prescription,SANDOZ CANADA INC,SOLUTION (INTRAVENOUS),2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML,ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K,Label,2000-05-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21163lbl.pdf
21184,1,TAZORAC,N021184,Prescription,ALLERGAN,CREAM (TOPICAL),0.05%,TAZAROTENE,Letter,2000-09-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21184ltr.pdf
21184,2,TAZORAC,N021184,Prescription,ALLERGAN,CREAM (TOPICAL),0.10%,TAZAROTENE,Letter,2000-09-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21184ltr.pdf
21184,3,AVAGE,N021184,Prescription,ALLERGAN,CREAM (TOPICAL),0.10%,TAZAROTENE,Letter,2000-09-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21184ltr.pdf
21197,1,CETROTIDE,N021197,Prescription,EMD SERONO INC,INJECTABLE (INJECTION),EQ 0.25MG BASE/ML,CETRORELIX,Label,2000-08-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21197lbl.pdf
21197,2,CETROTIDE,N021197,Discontinued,EMD SERONO INC,INJECTABLE (INJECTION),EQ 3MG BASE/ML,CETRORELIX,Label,2000-08-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21197lbl.pdf
21201,1,ASCLERA,N021201,Prescription,CHEMISCH FBRK KRSSLR,SOLUTION (INTRAVENOUS),10MG/2ML (5MG/ML),POLIDOCANOL,Label,2010-04-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021201lbl.pdf
21201,2,ASCLERA,N021201,Prescription,CHEMISCH FBRK KRSSLR,SOLUTION (INTRAVENOUS),20MG/2ML (10MG/ML),POLIDOCANOL,Label,2010-04-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021201lbl.pdf
21232,1,ORFADIN,N021232,Prescription,SWEDISH ORPHAN,CAPSULE (ORAL),2MG,NITISINONE,Label,2002-01-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21232lbl.pdf
21232,2,ORFADIN,N021232,Prescription,SWEDISH ORPHAN,CAPSULE (ORAL),5MG,NITISINONE,Label,2002-01-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21232lbl.pdf
21232,3,ORFADIN,N021232,Prescription,SWEDISH ORPHAN,CAPSULE (ORAL),10MG,NITISINONE,Label,2002-01-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21232lbl.pdf
21232,4,ORFADIN,N021232,Prescription,SWEDISH ORPHAN,CAPSULE (ORAL),20MG,NITISINONE,Label,2002-01-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21232lbl.pdf
21234,1,FLECTOR,N021234,Prescription,INST BIOCHEM,SYSTEM (TOPICAL),1.30%,DICLOFENAC EPOLAMINE,Label,2007-02-02T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021234lbl.pdf
21258,1,CLIMARA PRO,N021258,Prescription,BAYER HLTHCARE,"FILM, EXTENDED RELEASE (TRANSDERMAL)",0.045MG/24HR;0.015MG/24HR,ESTRADIOL; LEVONORGESTREL,Letter,2003-11-28T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21258ltr.pdf
21264,1,APOKYN,N021264,Discontinued,MDD US,INJECTABLE (SUBCUTANEOUS),20MG/2ML (10MG/ML),APOMORPHINE HYDROCHLORIDE,Letter,2004-04-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21264ltr.pdf
21264,2,APOKYN,N021264,Prescription,MDD US,INJECTABLE (SUBCUTANEOUS),30MG/3ML (10MG/ML),APOMORPHINE HYDROCHLORIDE,Letter,2004-04-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21264ltr.pdf
21265,1,INFUVITE PEDIATRIC,N021265,Prescription,SANDOZ CANADA INC,INJECTABLE (INTRAVENOUS),"80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL",ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K,Letter,2001-02-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-265_Infuvite%20Pediatric_Approv.pdf
21265,1,INFUVITE PEDIATRIC,N021265,Prescription,SANDOZ CANADA INC,INJECTABLE (INTRAVENOUS),"80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL",ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL HYDROCHLORIDE; VITAMIN A; VITAMIN K,Letter,2001-02-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-265_Infuvite%20Pediatric_Approv.pdf
21265,2,INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE),N021265,Prescription,SANDOZ CANADA INC,INJECTABLE (INTRAVENOUS),"80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL",ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K,Letter,2001-02-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-265_Infuvite%20Pediatric_Approv.pdf
21265,2,INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE),N021265,Prescription,SANDOZ CANADA INC,INJECTABLE (INTRAVENOUS),"80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL",ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL HYDROCHLORIDE; VITAMIN A; VITAMIN K,Letter,2001-02-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-265_Infuvite%20Pediatric_Approv.pdf
21269,1,CARDURA XL,N021269,Prescription,UPJOHN,"TABLET, EXTENDED RELEASE (ORAL)",EQ 4MG BASE,DOXAZOSIN MESYLATE,Label,2005-02-23T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021269lbl.pdf
21269,2,CARDURA XL,N021269,Prescription,UPJOHN,"TABLET, EXTENDED RELEASE (ORAL)",EQ 8MG BASE,DOXAZOSIN MESYLATE,Label,2005-02-23T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021269lbl.pdf
21288,1,TRELSTAR,N021288,Prescription,VERITY,INJECTABLE (INTRAMUSCULAR),EQ 11.25MG BASE/VIAL,TRIPTORELIN PAMOATE,Letter,2001-06-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/21288ltr.pdf
21305,2,HICON,N021305,Discontinued,JUBILANT,SOLUTION (ORAL),1-250mCi/0.25ML,SODIUM IODIDE I-131,Letter,2003-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21305ltr.pdf
21305,3,HICON,N021305,Discontinued,JUBILANT,SOLUTION (ORAL),1-500mCi/0.5ML,SODIUM IODIDE I-131,Letter,2003-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21305ltr.pdf
21305,4,SODIUM IODIDE I 131,N021305,Discontinued,JUBILANT,CAPSULE (ORAL),2-200mCi,SODIUM IODIDE I-131,Letter,2003-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21305ltr.pdf
21305,5,HICON,N021305,Discontinued,JUBILANT,SOLUTION (ORAL),1-1000mCi/ML,SODIUM IODIDE I-131,Letter,2003-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21305ltr.pdf
21305,6,SODIUM IODIDE I 131,N021305,Prescription,JUBILANT,CAPSULE (ORAL),0.009-0.1mCi,SODIUM IODIDE I-131,Letter,2003-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21305ltr.pdf
21305,7,HICON,N021305,Prescription,JUBILANT,SOLUTION (ORAL),250-1000mCi,SODIUM IODIDE I-131,Letter,2003-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21305ltr.pdf
21314,1,IDKIT:HP,N021314,Prescription,EXALENZ BIOSCIENCE,"FOR SOLUTION, TABLET, FOR SOLUTION (ORAL)","N/A,4GM;75MG,N/A",CITRIC ACID; UREA C-13,Label,2003-04-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21314_BreathID_lbl.pdf
21316,1,ALTOPREV,N021316,Discontinued,COVIS,"TABLET, EXTENDED RELEASE (ORAL)",10MG,LOVASTATIN,Letter,2002-06-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21316ltr.pdf
21316,2,ALTOPREV,N021316,Prescription,COVIS,"TABLET, EXTENDED RELEASE (ORAL)",20MG,LOVASTATIN,Letter,2002-06-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21316ltr.pdf
21316,3,ALTOPREV,N021316,Prescription,COVIS,"TABLET, EXTENDED RELEASE (ORAL)",40MG,LOVASTATIN,Letter,2002-06-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21316ltr.pdf
21316,4,ALTOPREV,N021316,Prescription,COVIS,"TABLET, EXTENDED RELEASE (ORAL)",60MG,LOVASTATIN,Letter,2002-06-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21316ltr.pdf
21336,1,EMSAM,N021336,Prescription,SOMERSET,"FILM, EXTENDED RELEASE (TRANSDERMAL)",6MG/24HR,SELEGILINE,Letter,2006-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021708s000_021336s000ltr.pdf
21336,2,EMSAM,N021336,Prescription,SOMERSET,"FILM, EXTENDED RELEASE (TRANSDERMAL)",9MG/24HR,SELEGILINE,Letter,2006-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021708s000_021336s000ltr.pdf
21336,3,EMSAM,N021336,Prescription,SOMERSET,"FILM, EXTENDED RELEASE (TRANSDERMAL)",12MG/24HR,SELEGILINE,Letter,2006-03-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021708s000_021336s000ltr.pdf
21355,1,ANGELIQ,N021355,Prescription,BAYER HLTHCARE,TABLET (ORAL),0.25MG;0.5MG,DROSPIRENONE; ESTRADIOL,Label,2005-09-30T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021355lbl.pdf
21355,2,ANGELIQ,N021355,Prescription,BAYER HLTHCARE,TABLET (ORAL),0.5MG;1MG,DROSPIRENONE; ESTRADIOL,Label,2005-09-30T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021355lbl.pdf
21450,3,ZOMIG,N021450,Prescription,ASTRAZENECA,SPRAY (NASAL),2.5MG/SPRAY,ZOLMITRIPTAN,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/21450 zolmitriptan clinical prea.pdf
21450,4,ZOMIG,N021450,Prescription,ASTRAZENECA,SPRAY (NASAL),5MG/SPRAY,ZOLMITRIPTAN,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/21450 zolmitriptan clinical prea.pdf
21479,1,ZELAPAR,N021479,Prescription,BAUSCH,"TABLET, ORALLY DISINTEGRATING (ORAL)",1.25MG,SELEGILINE HYDROCHLORIDE,Label,2006-06-20T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021479lbl.pdf
21481,1,FUZEON,N021481,Prescription,ROCHE,INJECTABLE (SUBCUTANEOUS),90MG/VIAL,ENFUVIRTIDE,Label,2003-03-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021481lbl.pdf
21503,1,VIRACEPT,N021503,Prescription,AGOURON PHARMS,TABLET (ORAL),EQ 625MG BASE,NELFINAVIR MESYLATE,Label,2003-05-06T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021503lbl.pdf
21560,1,ZORTRESS,N021560,Prescription,NOVARTIS,TABLET (ORAL),0.25MG,EVEROLIMUS,Letter,2010-04-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021560s000ltr.pdf
21560,2,ZORTRESS,N021560,Prescription,NOVARTIS,TABLET (ORAL),0.5MG,EVEROLIMUS,Letter,2010-04-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021560s000ltr.pdf
21560,3,ZORTRESS,N021560,Prescription,NOVARTIS,TABLET (ORAL),0.75MG,EVEROLIMUS,Letter,2010-04-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021560s000ltr.pdf
21560,4,ZORTRESS,N021560,Prescription,NOVARTIS,TABLET (ORAL),1MG,EVEROLIMUS,Letter,2010-04-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021560s000ltr.pdf
21569,1,SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N021569,Discontinued,LIEBEL-FLARSHEIM,INJECTABLE (INJECTION),405MG/50ML (9MG/ML),SODIUM CHLORIDE,Letter,2006-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021569s000ltr.pdf
21569,2,SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N021569,Prescription,LIEBEL-FLARSHEIM,INJECTABLE (INJECTION),1012.5MG/125ML (9MG/ML),SODIUM CHLORIDE,Letter,2006-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021569s000ltr.pdf
21612,1,LIPOFEN,N021612,Prescription,CIPHER PHARMS INC,CAPSULE (ORAL),50MG,FENOFIBRATE,Letter,2006-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/21612s000ltr.pdf
21612,2,LIPOFEN,N021612,Discontinued,CIPHER PHARMS INC,CAPSULE (ORAL),100MG,FENOFIBRATE,Letter,2006-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/21612s000ltr.pdf
21612,3,LIPOFEN,N021612,Prescription,CIPHER PHARMS INC,CAPSULE (ORAL),150MG,FENOFIBRATE,Letter,2006-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/21612s000ltr.pdf
21625,1,M.V.I. ADULT,N021625,Prescription,HOSPIRA,INJECTABLE (INTRAVENOUS),200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL,ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K,Letter,2004-02-03T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21625ltr.pdf
21643,1,M.V.I. ADULT (PHARMACY BULK PACKAGE),N021643,Prescription,HOSPIRA,INJECTABLE (INTRAVENOUS),200MG/5ML;0.06MG/5ML;0.005MG/5ML;15MG/5ML;0.005MG/5ML;0.6MG/5ML;40MG/5ML;6MG/5ML;3.6MG/5ML;6MG/5ML;1MG/5ML;10MG/5ML;0.15MG/5ML,ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K,Letter,2004-02-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21643ltr.pdf
21670,1,VISIONBLUE,N021670,Prescription,DORC,SOLUTION (OPHTHALMIC),0.06%,TRYPAN BLUE,Label,2004-12-30T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021670lbl.pdf
21674,1,MENOSTAR,N021674,Prescription,BAYER HLTHCARE,SYSTEM (TRANSDERMAL),0.014MG/24HR,ESTRADIOL,Letter,2004-06-10T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21674ltr.pdf
21697,1,VAPRISOL,N021697,Discontinued,CUMBERLAND PHARMS,INJECTABLE (INTRAVENOUS),20MG/4ML (5MG/ML),CONIVAPTAN HYDROCHLORIDE,Label,2005-12-30T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021697lbl.pdf
21697,2,VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER,N021697,Prescription,CUMBERLAND PHARMS,INJECTABLE (INTRAVENOUS),20MG/100ML (0.2MG/ML),CONIVAPTAN HYDROCHLORIDE,Label,2005-12-30T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021697lbl.pdf
21703,1,PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER,N021703,Discontinued,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,2,PRISMASOL BGK 2/0 IN PLASTIC CONTAINER,N021703,Prescription,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,3,PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER,N021703,Prescription,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,4,PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER,N021703,Prescription,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,5,PRISMASOL BGK 4/0 IN PLASTIC CONTAINER,N021703,Discontinued,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,6,PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER,N021703,Prescription,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,7,PRISMASOL BK 0/0 IN PLASTIC CONTAINER,N021703,Discontinued,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,8,PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER,N021703,Discontinued,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,9,PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER,N021703,Discontinued,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,10,PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER,N021703,Discontinued,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,11,PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER,N021703,Prescription,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,12,PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER,N021703,Discontinued,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,13,PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER,N021703,Discontinued,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,14,PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER,N021703,Prescription,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21703,15,PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER,N021703,Prescription,BAXTER HLTHCARE CORP,INJECTABLE (INJECTION),N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML),CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021703lbl.pdf
21762,1,FOSAMAX PLUS D,N021762,Prescription,ORGANON,TABLET (ORAL),"EQ 70MG BASE;2,800 IU",ALENDRONATE SODIUM; CHOLECALCIFEROL,Letter,2005-04-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021762ltr.pdf
21762,2,FOSAMAX PLUS D,N021762,Prescription,ORGANON,TABLET (ORAL),"EQ 70MG BASE;5,600 IU",ALENDRONATE SODIUM; CHOLECALCIFEROL,Letter,2005-04-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021762ltr.pdf
21779,1,VENTAVIS,N021779,Discontinued,ACTELION,SOLUTION (INHALATION),20MCG/2ML (10MCG/ML),ILOPROST,Letter,2005-01-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021779ltr.pdf
21779,2,VENTAVIS,N021779,Prescription,ACTELION,SOLUTION (INHALATION),10MCG/ML (10MCG/ML),ILOPROST,Letter,2005-01-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021779ltr.pdf
21779,3,VENTAVIS,N021779,Prescription,ACTELION,SOLUTION (INHALATION),20MCG/ML (20MCG/ML),ILOPROST,Letter,2005-01-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021779ltr.pdf
21780,1,NITROMIST,N021780,Prescription,EVUS,"AEROSOL, METERED (SUBLINGUAL)",0.4MG/SPRAY,NITROGLYCERIN,Letter,2006-11-06T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021780s000ltr.pdf
21785,1,INVIRASE,N021785,Prescription,HOFFMANN-LA ROCHE,TABLET (ORAL),EQ 500MG BASE,SAQUINAVIR MESYLATE,Label,2004-12-30T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021785lbl.pdf
21798,1,BARACLUDE,N021798,Prescription,BRISTOL MYERS SQUIBB,SOLUTION (ORAL),0.05MG/ML,ENTECAVIR,Label,2005-03-31T00:00:00Z,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021797,021798lbl.pdf"
21807,1,SOLTAMOX,N021807,Prescription,MAYNE PHARMA INC,SOLUTION (ORAL),EQ 20MG BASE/10ML,TAMOXIFEN CITRATE,Label,2005-11-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021807lbl.pdf
21814,1,APTIVUS,N021814,Prescription,BOEHRINGER INGELHEIM,CAPSULE (ORAL),250MG,TIPRANAVIR,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021814_Tipranavir_Clinical_BPCA.pdf
21877,1,ARRANON,N021877,Prescription,NOVARTIS,INJECTABLE (INTRAVENOUS),250MG/50ML (5MG/ML),NELARABINE,Letter,2005-11-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021877ltr.pdf
21906,1,KALETRA,N021906,Prescription,ABBVIE,TABLET (ORAL),200MG;50MG,LOPINAVIR; RITONAVIR,Letter,2005-11-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021906ltr.pdf
21906,2,KALETRA,N021906,Prescription,ABBVIE,TABLET (ORAL),100MG;25MG,LOPINAVIR; RITONAVIR,Letter,2005-11-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021906ltr.pdf
21910,1,NORMOCARB HF 25,N021910,Prescription,DIALYSIS SUPS,SOLUTION (INJECTION),0.21GM/100ML;2.8GM/100ML;9.07GM/100ML,MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-07-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021910lbl.pdf
21910,2,NORMOCARB HF 35,N021910,Prescription,DIALYSIS SUPS,SOLUTION (INJECTION),0.21GM/100ML;3.97GM/100ML;8.3GM/100ML,MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,Label,2006-07-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021910lbl.pdf
21946,1,XOLEGEL,N021946,Prescription,ALMIRALL,GEL (TOPICAL),2%,KETOCONAZOLE,Label,2006-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021946lbl.pdf
21949,1,PULMICORT FLEXHALER,N021949,Prescription,ASTRAZENECA,"POWDER, METERED (INHALATION)",0.08MG/INH,BUDESONIDE,Label,2006-07-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021949lbl.pdf
21949,2,PULMICORT FLEXHALER,N021949,Prescription,ASTRAZENECA,"POWDER, METERED (INHALATION)",0.16MG/INH,BUDESONIDE,Label,2006-07-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021949lbl.pdf
21956,1,DUTOPROL,N021956,Discontinued,CONCORDIA,"TABLET, EXTENDED RELEASE (ORAL)",12.5MG;EQ 25MG TARTRATE,HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE,Label,2006-08-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021956lbl.pdf
21956,2,DUTOPROL,N021956,Discontinued,CONCORDIA,"TABLET, EXTENDED RELEASE (ORAL)",12.5MG;EQ 50MG TARTRATE,HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE,Label,2006-08-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021956lbl.pdf
21956,3,DUTOPROL,N021956,Discontinued,CONCORDIA,"TABLET, EXTENDED RELEASE (ORAL)",12.5MG;EQ 100MG TARTRATE,HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE,Label,2006-08-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021956lbl.pdf
21957,1,NEXIUM,N021957,Prescription,ASTRAZENECA,"FOR SUSPENSION, DELAYED RELEASE (ORAL)",EQ 20MG BASE/PACKET,ESOMEPRAZOLE MAGNESIUM,Letter,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021957s000ltr.pdf
21957,2,NEXIUM,N021957,Prescription,ASTRAZENECA,"FOR SUSPENSION, DELAYED RELEASE (ORAL)",EQ 40MG BASE/PACKET,ESOMEPRAZOLE MAGNESIUM,Letter,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021957s000ltr.pdf
21957,3,NEXIUM,N021957,Prescription,ASTRAZENECA,"FOR SUSPENSION, DELAYED RELEASE (ORAL)",EQ 2.5MG BASE/PACKET,ESOMEPRAZOLE MAGNESIUM,Letter,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021957s000ltr.pdf
21957,4,NEXIUM,N021957,Prescription,ASTRAZENECA,"FOR SUSPENSION, DELAYED RELEASE (ORAL)",EQ 5MG BASE/PACKET,ESOMEPRAZOLE MAGNESIUM,Letter,2006-10-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021957s000ltr.pdf
22038,1,DIVIGEL,N022038,Prescription,VERTICAL PHARMS LLC,GEL (TRANSDERMAL),0.10%,ESTRADIOL,Label,2007-06-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022038lbl.pdf
22056,1,PRILOSEC,N022056,Prescription,COVIS,"FOR SUSPENSION, DELAYED RELEASE (ORAL)",EQ 2.5MG BASE/PACKET,OMEPRAZOLE MAGNESIUM,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/22056s000_Omeprazole_Clinical_PREA.pdf
22056,2,PRILOSEC,N022056,Prescription,COVIS,"FOR SUSPENSION, DELAYED RELEASE (ORAL)",EQ 10MG BASE/PACKET,OMEPRAZOLE MAGNESIUM,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/22056s000_Omeprazole_Clinical_PREA.pdf
22057,1,ENDOMETRIN,N022057,Prescription,FERRING,INSERT (VAGINAL),100MG,PROGESTERONE,Label,2007-06-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022057lbl.pdf
22116,1,LEXIVA,N022116,Prescription,VIIV HLTHCARE,SUSPENSION (ORAL),EQ 50MG BASE/ML,FOSAMPRENAVIR CALCIUM,Label,2007-06-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022116lbl.pdf
22141,1,CIMDUO,N022141,Prescription,MYLAN LABS LTD,TABLET (ORAL),300MG;300MG,LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/253_22141-lamivudine-and-tenofovir-clinical-prea.pdf
22173,1,ZYPREXA RELPREVV,N022173,Prescription,ELI LILLY CO,"SUSPENSION, EXTENDED RELEASE (INTRAMUSCULAR)",EQ 210MG BASE/VIAL,OLANZAPINE PAMOATE,Label,2009-12-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022173lbl.pdf
22173,2,ZYPREXA RELPREVV,N022173,Prescription,ELI LILLY CO,"SUSPENSION, EXTENDED RELEASE (INTRAMUSCULAR)",EQ 300MG BASE/VIAL,OLANZAPINE PAMOATE,Label,2009-12-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022173lbl.pdf
22173,3,ZYPREXA RELPREVV,N022173,Prescription,ELI LILLY CO,"SUSPENSION, EXTENDED RELEASE (INTRAMUSCULAR)",EQ 405MG BASE/VIAL,OLANZAPINE PAMOATE,Label,2009-12-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022173lbl.pdf
22186,1,AK-FLUOR 10%,N022186,Prescription,AKORN,INJECTABLE (INTRAVENOUS),EQ 500MG BASE/5ML (EQ 100MG BASE/ML),FLUORESCEIN SODIUM,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022186s000ltr.pdf
22186,2,AK-FLUOR 25%,N022186,Prescription,AKORN,INJECTABLE (INTRAVENOUS),EQ 500MG BASE/2ML (EQ 250MG BASE/ML),FLUORESCEIN SODIUM,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022186s000ltr.pdf
22212,1,DUREZOL,N022212,Prescription,NOVARTIS,EMULSION (OPHTHALMIC),0.05%,DIFLUPREDNATE,Letter,2008-06-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022212s000ltr.pdf
22234,1,DOCETAXEL,N022234,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),20MG/2ML (10MG/ML),DOCETAXEL,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022234s000ltr.pdf
22234,2,DOCETAXEL,N022234,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),80MG/8ML (10MG/ML),DOCETAXEL,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022234s000ltr.pdf
22234,3,DOCETAXEL,N022234,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),160MG/16ML (10MG/ML),DOCETAXEL,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022234s000ltr.pdf
22234,4,DOCETAXEL,N022234,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),20MG/ML (20MG/ML),DOCETAXEL,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022234s000ltr.pdf
22234,5,DOCETAXEL,N022234,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),80MG/4ML (20MG/ML),DOCETAXEL,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022234s000ltr.pdf
22234,6,DOCETAXEL,N022234,Discontinued,HOSPIRA INC,INJECTABLE (INJECTION),120MG/6ML (20MG/ML),DOCETAXEL,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022234s000ltr.pdf
22234,7,DOCETAXEL,N022234,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),160MG/8ML (20MG/ML),DOCETAXEL,Letter,2008-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022234s000ltr.pdf
22268,1,COARTEM,N022268,Prescription,NOVARTIS,TABLET (ORAL),20MG;120MG,ARTEMETHER; LUMEFANTRINE,Letter,2009-04-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022268s000ltr.pdf
22276,1,NICARDIPINE HYDROCHLORIDE,N022276,Prescription,EXELA PHARMA SCIENCE,INJECTABLE (INJECTION),25MG/10ML (2.5MG/ML),NICARDIPINE HYDROCHLORIDE,Label,2008-07-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022276lbl.pdf
22276,2,NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE,N022276,Prescription,EXELA PHARMA SCIENCE,INJECTABLE (INTRAVENOUS),20MG/200ML (0.1MG/ML),NICARDIPINE HYDROCHLORIDE,Label,2008-07-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022276lbl.pdf
22276,3,NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE,N022276,Prescription,EXELA PHARMA SCIENCE,INJECTABLE (INTRAVENOUS),40MG/200ML (0.2MG/ML),NICARDIPINE HYDROCHLORIDE,Label,2008-07-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022276lbl.pdf
22278,1,MEMBRANEBLUE,N022278,Prescription,DORC,SOLUTION (OPHTHALMIC),0.15%,TRYPAN BLUE,Letter,2009-02-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022278s000ltr.pdf
22290,1,ADREVIEW,N022290,Prescription,GE HEALTHCARE,SOLUTION (INTRAVENOUS),10mCi/5ML (2mCi/ML),IOBENGUANE SULFATE I-123,Label,2008-09-19T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/22290lbl.pdf
22292,1,APTIVUS,N022292,Prescription,BOEHRINGER INGELHEIM,SOLUTION (ORAL),100MG/ML,TIPRANAVIR,Letter,2008-06-26T00:00:00Z,"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021814s005, 022292s000ltr.pdf"
22382,1,SPRIX,N022382,Prescription,ZYLA,"SPRAY, METERED (NASAL)",15.75MG/SPRAY,KETOROLAC TROMETHAMINE,Letter,2010-05-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022382s000ltr.pdf
22454,1,DATSCAN,N022454,Prescription,GE HLTHCARE INC,SOLUTION (INTRAVENOUS),5mCi/2.5ML (2mCi/ML),IOFLUPANE I-123,Letter,2011-01-20T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022454s000ltr.pdf
22466,1,ORABLOC,N022466,Prescription,PIERREL,INJECTABLE (INJECTION),4%;EQ 0.009MG BASE/1.8ML (EQ 0.005MG BASE/ML),ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE,Label,2010-03-02T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022466lbl.pdf
22466,2,ORABLOC,N022466,Prescription,PIERREL,INJECTABLE (INJECTION),4%;EQ 0.018MG BASE/1.8ML (EQ 0.01MG BASE/ML),ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE,Label,2010-03-02T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022466lbl.pdf
22536,1,INDOMETHACIN,N022536,Prescription,FRESENIUS KABI USA,INJECTABLE (INJECTION),EQ 1MG BASE/VIAL,INDOMETHACIN,Label,2010-03-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022536lbl.pdf
22562,1,CARBAGLU,N022562,Prescription,RECORDATI RARE,"TABLET, FOR SUSPENSION (ORAL)",200MG,CARGLUMIC ACID,Label,2010-03-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022562lbl.pdf
50114,1,PRE-PEN,N050114,Prescription,ALLERQUEST,INJECTABLE (INJECTION),60UMOLAR,BENZYLPENICILLOYL POLYLYSINE,,,
50138,1,BICILLIN C-R,N050138,Prescription,KING PHARMS LLC,INJECTABLE (INJECTION),"300,000 UNITS/ML;300,000 UNITS/ML",PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE,,,
50138,2,BICILLIN C-R,N050138,Discontinued,KING PHARMS LLC,INJECTABLE (INJECTION),"150,000 UNITS/ML;150,000 UNITS/ML",PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE,,,
50138,3,BICILLIN C-R 900/300,N050138,Prescription,KING PHARMS LLC,INJECTABLE (INJECTION),"900,000 UNITS/2ML;300,000 UNITS/2ML",PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE,,,
50480,1,VIBRAMYCIN,N050480,Prescription,PFIZER,SUSPENSION (ORAL),EQ 50MG BASE/5ML,DOXYCYCLINE CALCIUM,,,
50577,1,ZANOSAR,N050577,Prescription,TEVA PHARMS USA,INJECTABLE (INJECTION),1GM/VIAL,STREPTOZOCIN,,,
50616,1,TOBRADEX,N050616,Prescription,NOVARTIS,OINTMENT (OPHTHALMIC),0.1%;0.3%,DEXAMETHASONE; TOBRAMYCIN,,,
50625,1,SANDIMMUNE,N050625,Prescription,NOVARTIS,CAPSULE (ORAL),25MG,CYCLOSPORINE,,,
50625,2,SANDIMMUNE,N050625,Prescription,NOVARTIS,CAPSULE (ORAL),100MG,CYCLOSPORINE,,,
50625,3,SANDIMMUNE,N050625,Prescription,NOVARTIS,CAPSULE (ORAL),50MG,CYCLOSPORINE,,,
50629,1,DOXORUBICIN HYDROCHLORIDE,N050629,Prescription,PFIZER,INJECTABLE (INJECTION),2MG/ML,DOXORUBICIN HYDROCHLORIDE,,,
50629,2,DOXORUBICIN HYDROCHLORIDE,N050629,Prescription,PFIZER,INJECTABLE (INJECTION),200MG/100ML,DOXORUBICIN HYDROCHLORIDE,,,
50629,3,DOXORUBICIN HYDROCHLORIDE,N050629,Prescription,PFIZER,INJECTABLE (INJECTION),150MG/75ML,DOXORUBICIN HYDROCHLORIDE,,,
50635,1,CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%,N050635,Prescription,ABRAXIS PHARM,INJECTABLE (INJECTION),EQ 900MG BASE/100ML,CLINDAMYCIN PHOSPHATE,,,
50638,1,PENICILLIN G POTASSIUM IN PLASTIC CONTAINER,N050638,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),"20,000 UNITS/ML",PENICILLIN G POTASSIUM,,,
50638,2,PENICILLIN G POTASSIUM IN PLASTIC CONTAINER,N050638,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),"40,000 UNITS/ML",PENICILLIN G POTASSIUM,,,
50638,3,PENICILLIN G POTASSIUM IN PLASTIC CONTAINER,N050638,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),"60,000 UNITS/ML",PENICILLIN G POTASSIUM,,,
50640,1,BACTOCILL IN PLASTIC CONTAINER,N050640,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 20MG BASE/ML,OXACILLIN SODIUM,,,
50640,2,BACTOCILL IN PLASTIC CONTAINER,N050640,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 40MG BASE/ML,OXACILLIN SODIUM,,,
50655,1,NALLPEN IN PLASTIC CONTAINER,N050655,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 20MG BASE/ML,NAFCILLIN SODIUM,,,
50655,2,NALLPEN IN PLASTIC CONTAINER,N050655,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 2GM BASE/100ML,NAFCILLIN SODIUM,,,
50671,1,VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER,N050671,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 500MG BASE/100ML,VANCOMYCIN HYDROCHLORIDE,,,
50671,2,VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER,N050671,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 750MG BASE/150ML,VANCOMYCIN HYDROCHLORIDE,,,
50671,3,VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER,N050671,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 1GM BASE/200ML,VANCOMYCIN HYDROCHLORIDE,,,
50693,1,ZITHROMAX,N050693,Prescription,PFIZER,FOR SUSPENSION (ORAL),EQ 1GM BASE/PACKET,AZITHROMYCIN,Other Important Information from FDA,2013-03-12T00:00:00Z,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm343281.htm
50740,1,AMBISOME,N050740,Prescription,ASTELLAS,"INJECTABLE, LIPOSOMAL (INJECTION)",50MG/VIAL,AMPHOTERICIN B,Review,2009-06-19T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/050740_ambisome_toc.cfm
50748,1,SYNERCID,N050748,Prescription,KING PHARMS,INJECTABLE (INTRAVENOUS),350MG/VIAL;150MG/VIAL,DALFOPRISTIN; QUINUPRISTIN,Label,1999-09-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50748lbl.pdf
50748,2,SYNERCID,N050748,Discontinued,KING PHARMS,INJECTABLE (INTRAVENOUS),420MG/VIAL;180MG/VIAL,DALFOPRISTIN; QUINUPRISTIN,Label,1999-09-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50748lbl.pdf
50767,1,CLEOCIN,N050767,Prescription,PFIZER,SUPPOSITORY (VAGINAL),100MG,CLINDAMYCIN PHOSPHATE,Label,1999-08-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50767lbl.pdf
50779,1,CEFAZOLIN AND DEXTROSE,N050779,Discontinued,B BRAUN,INJECTABLE (INJECTION),EQ 500MG BASE/VIAL,CEFAZOLIN SODIUM,Letter,2000-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/50779ltr.pdf
50779,2,CEFAZOLIN AND DEXTROSE,N050779,Prescription,B BRAUN,INJECTABLE (INJECTION),EQ 1GM BASE/VIAL,CEFAZOLIN SODIUM,Letter,2000-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/50779ltr.pdf
50779,3,CEFAZOLIN AND DEXTROSE,N050779,Prescription,B BRAUN,INJECTABLE (INJECTION),EQ 2GM BASE/VIAL,CEFAZOLIN SODIUM,Letter,2000-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/50779ltr.pdf
50782,1,CLINDAGEL,N050782,Prescription,BAUSCH,GEL (TOPICAL),EQ 1% BASE,CLINDAMYCIN PHOSPHATE,Letter,2000-11-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/50782LTR-LBL.PDF
50786,1,PYLERA,N050786,Prescription,ALLERGAN,CAPSULE (ORAL),140MG;125MG;125MG,BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE,Letter,2006-10-02T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/050786s000LTR.pdf
50803,1,VELTIN,N050803,Prescription,ALMIRALL,GEL (TOPICAL),1.2%;0.025%,CLINDAMYCIN PHOSPHATE; TRETINOIN,Letter,2010-07-20T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/050803s000ltr.pdf
50804,1,ZYLET,N050804,Prescription,BAUSCH AND LOMB,SUSPENSION/DROPS (OPHTHALMIC),0.5%;0.3%,LOTEPREDNOL ETABONATE; TOBRAMYCIN,Letter,2004-12-30T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/050804ltr.pdf
50810,1,AZASITE,N050810,Prescription,AKORN,SOLUTION/DROPS (OPHTHALMIC),1%,AZITHROMYCIN,Letter,2007-05-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/050810s000ltr.pdf
50817,1,CEFEPIME IN PLASTIC CONTAINER,N050817,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 1GM BASE/50ML (EQ 20MG BASE/ML),CEFEPIME HYDROCHLORIDE,Letter,2008-08-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050817s000ltr.pdf
50817,2,CEFEPIME IN PLASTIC CONTAINER,N050817,Prescription,BAXTER HLTHCARE,INJECTABLE (INJECTION),EQ 2GM BASE/100ML (EQ 20MG BASE/ML),CEFEPIME HYDROCHLORIDE,Letter,2008-08-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050817s000ltr.pdf
50823,1,CEFTAZIDIME IN DEXTROSE CONTAINER,N050823,Prescription,B BRAUN,INJECTABLE (INJECTION),EQ 1GM BASE,CEFTAZIDIME,Letter,2011-06-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/050823s000ltr.pdf
50823,2,CEFTAZIDIME IN DEXTROSE CONTAINER,N050823,Prescription,B BRAUN,INJECTABLE (INJECTION),EQ 2GM BASE,CEFTAZIDIME,Letter,2011-06-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/050823s000ltr.pdf
50824,1,OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN,N050824,Discontinued,CUMBERLAND PHARMS,"CAPSULE, TABLET, CAPSULE, DELAYED RELEASE (ORAL)","500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG",AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE,Label,2011-02-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050824s000lbl.pdf
65430,1,CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER,N065430,Prescription,B BRAUN,INJECTABLE (INJECTION),EQ 1GM BASE/VIAL,CEFOTETAN DISODIUM,Letter,2007-08-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/065430ltr.pdf
65430,2,CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER,N065430,Prescription,B BRAUN,INJECTABLE (INJECTION),EQ 2GM BASE/VIAL,CEFOTETAN DISODIUM,Letter,2007-08-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/065430ltr.pdf
200671,1,DURLAZA,N200671,Prescription,ESPERO,"CAPSULE, EXTENDED RELEASE (ORAL)",162.5MG,ASPIRIN,Label,2015-09-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/200671s000lbl.pdf
200738,1,LOTEMAX,N200738,Prescription,BAUSCH AND LOMB,OINTMENT (OPHTHALMIC),0.50%,LOTEPREDNOL ETABONATE,Label,2011-04-18T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/200738s000lbl.pdf
200740,1,CYSTARAN,N200740,Prescription,LEADIANT BIOSCI INC,SOLUTION/DROPS (OPHTHALMIC),EQ 0.44% BASE,CYSTEAMINE HYDROCHLORIDE,Letter,2012-10-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/200740Orig1s000ltr.pdf
202106,1,MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER,N202106,Prescription,B BRAUN MEDICAL INC,POWDER (INTRAVENOUS),500MG/VIAL,MEROPENEM,Letter,2015-05-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202106Orig1s000ltr.pdf
202106,2,MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER,N202106,Prescription,B BRAUN MEDICAL INC,POWDER (INTRAVENOUS),1GM/VIAL,MEROPENEM,Letter,2015-05-05T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202106Orig1s000ltr.pdf
202515,1,MORPHINE SULFATE,N202515,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),2MG/ML,MORPHINE SULFATE,Label,2011-11-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202515Orig1s000Lbl.pdf
202515,2,MORPHINE SULFATE,N202515,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),4MG/ML,MORPHINE SULFATE,Label,2011-11-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202515Orig1s000Lbl.pdf
202515,3,MORPHINE SULFATE,N202515,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),8MG/ML,MORPHINE SULFATE,Label,2011-11-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202515Orig1s000Lbl.pdf
202515,4,MORPHINE SULFATE,N202515,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),10MG/ML,MORPHINE SULFATE,Label,2011-11-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202515Orig1s000Lbl.pdf
202515,5,MORPHINE SULFATE,N202515,Discontinued,HOSPIRA INC,INJECTABLE (INJECTION),15MG/ML,MORPHINE SULFATE,Label,2011-11-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202515Orig1s000Lbl.pdf
202515,6,MORPHINE SULFATE,N202515,Prescription,HOSPIRA INC,INJECTABLE (INJECTION),50MG/ML,MORPHINE SULFATE,Label,2011-11-14T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202515Orig1s000Lbl.pdf
202832,1,SODIUM CHLORIDE 0.9%,N202832,Prescription,MEDEFIL INC,INJECTABLE (INJECTION),9MG/ML (9MG/ML),SODIUM CHLORIDE,Letter,2012-01-10T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202832s000ltr.pdf
202832,2,SODIUM CHLORIDE 0.9%,N202832,Prescription,MEDEFIL INC,INJECTABLE (INJECTION),18MG/2ML (9MG/ML),SODIUM CHLORIDE,Letter,2012-01-10T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202832s000ltr.pdf
202832,3,SODIUM CHLORIDE 0.9%,N202832,Prescription,MEDEFIL INC,INJECTABLE (INJECTION),22.5MG/2.5ML (9MG/ML),SODIUM CHLORIDE,Letter,2012-01-10T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202832s000ltr.pdf
202832,4,SODIUM CHLORIDE 0.9%,N202832,Prescription,MEDEFIL INC,INJECTABLE (INJECTION),27MG/3ML (9MG/ML),SODIUM CHLORIDE,Letter,2012-01-10T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202832s000ltr.pdf
202832,5,SODIUM CHLORIDE 0.9%,N202832,Prescription,MEDEFIL INC,INJECTABLE (INJECTION),45MG/5ML (9MG/ML),SODIUM CHLORIDE,Letter,2012-01-10T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202832s000ltr.pdf
202832,6,SODIUM CHLORIDE 0.9%,N202832,Prescription,MEDEFIL INC,INJECTABLE (INJECTION),90MG/10ML (9MG/ML),SODIUM CHLORIDE,Letter,2012-01-10T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202832s000ltr.pdf
203551,1,DOCETAXEL,N203551,Prescription,ACTAVIS LLC,INJECTABLE (INJECTION),20MG/ML (20MG/ML),DOCETAXEL,Letter,2013-04-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203551Orig1s000ltr.pdf
203551,2,DOCETAXEL,N203551,Prescription,ACTAVIS LLC,INJECTABLE (INJECTION),80MG/4ML (20MG/ML),DOCETAXEL,Letter,2013-04-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203551Orig1s000ltr.pdf
203551,3,DOCETAXEL,N203551,Prescription,ACTAVIS LLC,INJECTABLE (INJECTION),140MG/7ML (20MG/ML),DOCETAXEL,Letter,2013-04-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203551Orig1s000ltr.pdf
203551,4,DOCETAXEL,N203551,Prescription,ACTAVIS LLC,INJECTABLE (INJECTION),160MG/8ML (20MG/ML),DOCETAXEL,Letter,2013-04-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203551Orig1s000ltr.pdf
203629,1,NEOSTIGMINE METHYLSULFATE,N203629,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),5MG/10ML (0.5MG/ML),NEOSTIGMINE METHYLSULFATE,Letter,2015-01-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203629Orig1s000ltr.pdf
203629,2,NEOSTIGMINE METHYLSULFATE,N203629,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),10MG/10ML (1MG/ML),NEOSTIGMINE METHYLSULFATE,Letter,2015-01-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203629Orig1s000ltr.pdf
203629,3,NEOSTIGMINE METHYLSULFATE,N203629,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),3MG/3ML (1MG/ML),NEOSTIGMINE METHYLSULFATE,Letter,2015-01-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203629Orig1s000ltr.pdf
204016,1,ZOLEDRONIC ACID,N204016,Prescription,HOSPIRA INC,SOLUTION (INTRAVENOUS),EQ 4MG BASE/100ML (EQ 0.04MG BASE/ML),ZOLEDRONIC ACID,Letter,2013-07-08T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204016Orig1s000ltr.pdf
204150,1,DESVENLAFAXINE,N204150,Prescription,ALEMBIC PHARMS LTD,"TABLET, EXTENDED RELEASE (ORAL)",50MG,DESVENLAFAXINE,Letter,2013-01-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/204150Orig1s000TAltr.pdf
204150,2,DESVENLAFAXINE,N204150,Prescription,ALEMBIC PHARMS LTD,"TABLET, EXTENDED RELEASE (ORAL)",100MG,DESVENLAFAXINE,Letter,2013-01-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/204150Orig1s000TAltr.pdf
204508,1,CLINOLIPID 20%,N204508,Prescription,BAXTER HLTHCARE CORP,EMULSION (INTRAVENOUS),16%(160GM/1000ML);4%  (40GM/1000ML),OLIVE OIL; SOYBEAN OIL,Letter,2013-10-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204508Orig1s000ltr.pdf
204630,1,PROVAYBLUE,N204630,Prescription,PROVEPHARM SAS,SOLUTION (INTRAVENOUS),50MG/10ML (5MG/ML),METHYLENE BLUE,Letter,2016-04-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204630Orig1s000ltr.pdf
204630,2,PROVAYBLUE,N204630,Prescription,PROVEPHARM SAS,SOLUTION (INTRAVENOUS),10MG/2ML (5MG/ML),METHYLENE BLUE,Letter,2016-04-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204630Orig1s000ltr.pdf
204684,1,IMPAVIDO,N204684,Prescription,KNIGHT THERAPS,CAPSULE (ORAL),50MG,MILTEFOSINE,Label,2014-03-20T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204684s000lbl.pdf
205572,1,MOXIFLOXACIN HYDROCHLORIDE,N205572,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),EQ 400MG BASE/250ML (EQ 1.6MG BASE/ML),MOXIFLOXACIN HYDROCHLORIDE,Letter,2015-04-08T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205572Orig1s000ltr.pdf
205582,1,DECITABINE,N205582,Prescription,SUN PHARMA GLOBAL,POWDER (INTRAVENOUS),50MG/VIAL,DECITABINE,Letter,2014-01-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205582Orig1s000ltr.pdf
205613,1,UCERIS,N205613,Prescription,SALIX,"AEROSOL, FOAM (RECTAL)",2MG/ACTUATION,BUDESONIDE,Letter,2014-09-17T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205613Orig1s000TAltr.pdf
205641,1,ASMANEX HFA,N205641,Prescription,ORGANON,"AEROSOL, METERED (INHALATION)",0.10MG/INH,MOMETASONE FUROATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/205641 mometasone clinical prea.pdf
205641,2,ASMANEX HFA,N205641,Prescription,ORGANON,"AEROSOL, METERED (INHALATION)",0.20MG/INH,MOMETASONE FUROATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/205641 mometasone clinical prea.pdf
205641,3,ASMANEX HFA,N205641,Prescription,ORGANON,"AEROSOL, METERED (INHALATION)",0.05MG/INH,MOMETASONE FUROATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/205641 mometasone clinical prea.pdf
205919,1,PURIXAN,N205919,Prescription,NOVA LABS LTD,SUSPENSION (ORAL),20MG/ML,MERCAPTOPURINE,Label,2014-04-28T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205919s000lbl.pdf
206289,1,ATROPINE SULFATE,N206289,Prescription,AKORN,SOLUTION/DROPS (OPHTHALMIC),1%,ATROPINE SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/82_206289 atropine clinical prea.pdf
206473,1,LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,N206473,Prescription,HOSPIRA INC,SOLUTION (INTRAVENOUS),600MG/300ML (2MG/ML),LINEZOLID,Label,2015-06-19T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206473s000lbl.pdf
206628,1,DEXMEDETOMIDINE HYDROCHLORIDE,N206628,Prescription,HQ SPCLT PHARMA,SOLUTION (INTRAVENOUS),EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Letter,2015-10-23T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206628Orig1s000ltr.pdf
206628,2,DEXMEDETOMIDINE HYDROCHLORIDE,N206628,Prescription,HQ SPCLT PHARMA,SOLUTION (INTRAVENOUS),EQ 1MG BASE/10ML (EQ 100MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Letter,2015-10-23T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206628Orig1s000ltr.pdf
206628,3,DEXMEDETOMIDINE HYDROCHLORIDE,N206628,Prescription,HQ SPCLT PHARMA,SOLUTION (INTRAVENOUS),EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Letter,2015-10-23T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206628Orig1s000ltr.pdf
206628,4,DEXMEDETOMIDINE HYDROCHLORIDE,N206628,Prescription,HQ SPCLT PHARMA,SOLUTION (INTRAVENOUS),EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML),DEXMEDETOMIDINE HYDROCHLORIDE,Letter,2015-10-23T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206628Orig1s000ltr.pdf
206927,1,BORTEZOMIB,N206927,Prescription,DR REDDYS LABS LTD,POWDER (INTRAVENOUS),3.5MG/VIAL,BORTEZOMIB,Label,2019-10-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206927s000lbl.pdf
207131,1,CEFAZOLIN IN PLASTIC CONTAINER,N207131,Prescription,BAXTER HLTHCARE CORP,SOLUTION (INTRAVENOUS),EQ 2GM BASE/100ML (EQ 20MG BASE/ML),CEFAZOLIN SODIUM,Letter,2015-08-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/207131Orig1s000ltr.pdf
207131,2,CEFAZOLIN IN PLASTIC CONTAINER,N207131,Prescription,BAXTER HLTHCARE CORP,SOLUTION (INTRAVENOUS),EQ 1GM BASE/50ML (EQ 20MG BASE/ML),CEFAZOLIN SODIUM,Letter,2015-08-24T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/207131Orig1s000ltr.pdf
207534,1,SYMJEPI,N207534,Prescription,ADAMIS PHARMS CORP,"SOLUTION (INTRAMUSCULAR, SUBCUTANEOUS)",0.3MG/0.3ML (0.3MG/0.3ML),EPINEPHRINE,Label,2017-06-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207534lbl.pdf
207534,2,SYMJEPI,N207534,Prescription,ADAMIS PHARMS CORP,"SOLUTION (INTRAMUSCULAR, SUBCUTANEOUS)",0.15MG/0.3ML (0.15MG/0.3ML),EPINEPHRINE,Label,2017-06-15T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207534lbl.pdf
207926,1,PHENYLEPHRINE HYDROCHLORIDE,N207926,Prescription,AKORN,SOLUTION/DROPS (OPHTHALMIC),2.50%,PHENYLEPHRINE HYDROCHLORIDE,Label,2015-01-20T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207926s000lbl.pdf
207926,2,PHENYLEPHRINE HYDROCHLORIDE,N207926,Prescription,AKORN,SOLUTION/DROPS (OPHTHALMIC),10%,PHENYLEPHRINE HYDROCHLORIDE,Label,2015-01-20T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207926s000lbl.pdf
207963,1,PALONOSETRON HYDROCHLORIDE,N207963,Prescription,HIKMA,SOLUTION (INTRAVENOUS),EQ 0.25MG BASE/2ML (EQ 0.125MG BASE/ML),PALONOSETRON HYDROCHLORIDE,Letter,2016-08-22T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/207963Orig1s000ltr.pdf
208036,1,E-Z-HD,N208036,Prescription,BRACCO,FOR SUSPENSION (ORAL),98% (334GM/BOT),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208036 barium sulfate clinical prea.pdf
208036,2,E-Z-PAQUE,N208036,Prescription,BRACCO,FOR SUSPENSION (ORAL),96% (169GM/BOT),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208036 barium sulfate clinical prea.pdf
208036,3,E-Z-CAT DRY,N208036,Discontinued,BRACCO,FOR SUSPENSION (ORAL),40% (9GM/POUCH),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208036 barium sulfate clinical prea.pdf
208036,4,VARIBAR THIN LIQUID,N208036,Prescription,BRACCO,FOR SUSPENSION (ORAL),81% (120GM/BOT),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208036 barium sulfate clinical prea.pdf
208083,1,CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE,N208083,Prescription,BAXTER HLTHCARE CORP,SOLUTION (INTRAVENOUS),EQ 300MG BASE/50ML (EQ 6MG BASE/ML),CLINDAMYCIN PHOSPHATE,Label,2017-04-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208083lbl.pdf
208083,2,CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE,N208083,Prescription,BAXTER HLTHCARE CORP,SOLUTION (INTRAVENOUS),EQ 600MG BASE/50ML (EQ 12MG BASE/ML),CLINDAMYCIN PHOSPHATE,Label,2017-04-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208083lbl.pdf
208083,3,CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE,N208083,Prescription,BAXTER HLTHCARE CORP,SOLUTION (INTRAVENOUS),EQ 900MG BASE/50ML (EQ 18MG BASE/ML),CLINDAMYCIN PHOSPHATE,Label,2017-04-21T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208083lbl.pdf
208109,1,PALONOSETRON HYDROCHLORIDE,N208109,Discontinued,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML),PALONOSETRON HYDROCHLORIDE,Label,2017-11-22T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208109s000lbl.pdf
208135,1,TETRACAINE HYDROCHLORIDE,N208135,Prescription,ALCON LABS,SOLUTION (OPHTHALMIC),0.50%,TETRACAINE HYDROCHLORIDE,Pediatric DD Summary Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208135 tetracaine DD clinical prea.pdf
208143,1,READI-CAT 2,N208143,Prescription,BRACCO,SUSPENSION (ORAL),2% (9GM/BOT),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208143 barium sulfate clinical prea.pdf
208143,2,READI-CAT 2 SMOOTHIE,N208143,Prescription,BRACCO,SUSPENSION (ORAL),2% (9GM/BOT),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208143 barium sulfate clinical prea.pdf
208143,3,LIQUID E-Z-PAQUE,N208143,Prescription,BRACCO,SUSPENSION (ORAL),60% (213GM/BOT),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208143 barium sulfate clinical prea.pdf
208143,4,VARIBAR NECTAR,N208143,Prescription,BRACCO,SUSPENSION (ORAL),40% (96GM/240ML),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208143 barium sulfate clinical prea.pdf
208143,5,TAGITOL V,N208143,Prescription,BRACCO,SUSPENSION (ORAL),40% (8GM/BOT),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208143 barium sulfate clinical prea.pdf
208143,6,VARIBAR THIN HONEY,N208143,Prescription,BRACCO,SUSPENSION (ORAL),40% (100GM/250ML),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208143 barium sulfate clinical prea.pdf
208143,7,VARIBAR HONEY,N208143,Prescription,BRACCO,SUSPENSION (ORAL),40% (100GM/250ML),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208143 barium sulfate clinical prea.pdf
208143,8,ENTERO VU 24%,N208143,Prescription,BRACCO,SUSPENSION (ORAL),24% (144GM/600ML),BARIUM SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208143 barium sulfate clinical prea.pdf
208151,1,ISOPTO ATROPINE,N208151,Prescription,ALCON LABS INC,SOLUTION/DROPS (OPHTHALMIC),1%,ATROPINE SULFATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/53_208151 atropine sulfate clinical prea.pdf
208374,1,BIVALIRUDIN IN 0.9% SODIUM CHLORIDE,N208374,Prescription,BAXTER HLTHCARE CORP,SOLUTION (INTRAVENOUS),250MG/50ML (5MG/ML),BIVALIRUDIN,Label,2017-12-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208374s000lbl.pdf
208374,2,BIVALIRUDIN IN 0.9% SODIUM CHLORIDE,N208374,Prescription,BAXTER HLTHCARE CORP,SOLUTION (INTRAVENOUS),500MG/100ML (5MG/ML),BIVALIRUDIN,Label,2017-12-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208374s000lbl.pdf
208418,1,CALCIUM GLUCONATE,N208418,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),1GM/10ML (100MG/ML),CALCIUM GLUCONATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/141_208418 calcium gluconate clinical prea.pdf
208418,2,CALCIUM GLUCONATE,N208418,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),5GM/50ML (100MG/ML),CALCIUM GLUCONATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/141_208418 calcium gluconate clinical prea.pdf
208418,3,CALCIUM GLUCONATE,N208418,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),10GM/100ML (100MG/ML),CALCIUM GLUCONATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/141_208418 calcium gluconate clinical prea.pdf
208574,1,ROMIDEPSIN,N208574,Discontinued,TEVA PHARMS USA INC,SOLUTION (INTRAVENOUS),10MG/2ML (5MG/ML),ROMIDEPSIN,Label,2020-03-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208574Orig2lbl.pdf
208574,2,ROMIDEPSIN,N208574,Prescription,TEVA PHARMS USA INC,SOLUTION (INTRAVENOUS),27.5MG/5.5ML (5MG/ML),ROMIDEPSIN,Label,2020-03-16T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208574Orig2lbl.pdf
208582,1,ALTAFLUOR BENOX,N208582,Prescription,ALTAIRE PHARMS INC,SOLUTION/DROPS (OPHTHALMIC),0.4%;0.25%,BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM,Letter,2017-12-20T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208582Orig1s000ltr.pdf
208844,1,VARIBAR PUDDING,N208844,Prescription,BRACCO,PASTE (ORAL),40%,BARIUM SULFATE,Pediatric DD Summary Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/208844 barium sulfate DD review prea.pdf
209359,1,EPINEPHRINE (COPACKAGED),N209359,Prescription,HOSPIRA INC,SOLUTION (INTRAVENOUS),1MG/10ML (0.1MG/ML),EPINEPHRINE,Letter,2019-11-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/209359Orig1s000ltr.pdf
209377,1,ZINC SULFATE,N209377,Prescription,AM REGENT,SOLUTION (INTRAVENOUS),EQ 30MG BASE/10ML (EQ 3MG BASE/ML),ZINC SULFATE,Pediatric Other,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/455_209377 zinc sulfate unireview prea_0.pdf
209377,2,ZINC SULFATE,N209377,Prescription,AM REGENT,SOLUTION (INTRAVENOUS),EQ 25MG BASE/5ML (EQ 5MG BASE/ML),ZINC SULFATE,Pediatric Other,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/455_209377 zinc sulfate unireview prea_0.pdf
209377,3,ZINC SULFATE,N209377,Prescription,AM REGENT,SOLUTION (INTRAVENOUS),EQ 10MG BASE/10ML (EQ 1MG BASE/ML),ZINC SULFATE,Pediatric Other,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/455_209377 zinc sulfate unireview prea_0.pdf
209387,1,NIPRIDE RTU IN SODIUM CHLORIDE 0.9%,N209387,Prescription,EXELA PHARMA,SOLUTION (INTRAVENOUS),50MG/100ML (0.5MG/ML),SODIUM NITROPRUSSIDE,Label,2017-03-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209387s000lbl.pdf
209387,2,NIPRIDE RTU IN SODIUM CHLORIDE 0.9%,N209387,Discontinued,EXELA PHARMA,SOLUTION (INTRAVENOUS),10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**,SODIUM NITROPRUSSIDE,Label,2017-03-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209387s000lbl.pdf
209387,3,NIPRIDE RTU IN SODIUM CHLORIDE 0.9%,N209387,Prescription,EXELA PHARMA,SOLUTION (INTRAVENOUS),20MG/100ML (0.2MG/ML),SODIUM NITROPRUSSIDE,Label,2017-03-09T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209387s000lbl.pdf
209481,1,VANCOMYCIN HYDROCHLORIDE,N209481,Prescription,MYLAN LABS LTD,POWDER (INTRAVENOUS),EQ 250MG BASE/VIAL,VANCOMYCIN HYDROCHLORIDE,Label,2018-07-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209481s000lbl.pdf
209481,2,VANCOMYCIN HYDROCHLORIDE,N209481,Prescription,MYLAN LABS LTD,POWDER (INTRAVENOUS),EQ 750MG BASE/VIAL,VANCOMYCIN HYDROCHLORIDE,Label,2018-07-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209481s000lbl.pdf
209481,3,VANCOMYCIN HYDROCHLORIDE,N209481,Prescription,MYLAN LABS LTD,POWDER (INTRAVENOUS),EQ 1.25GM BASE/VIAL,VANCOMYCIN HYDROCHLORIDE,Label,2018-07-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209481s000lbl.pdf
209481,4,VANCOMYCIN HYDROCHLORIDE,N209481,Prescription,MYLAN LABS LTD,POWDER (INTRAVENOUS),EQ 1.5GM BASE/VIAL,VANCOMYCIN HYDROCHLORIDE,Label,2018-07-11T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209481s000lbl.pdf
209512,1,NORVIR,N209512,Prescription,ABBVIE INC,POWDER (ORAL),100MG/PACKET,RITONAVIR,Label,2017-06-08T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209512lbl.pdf
209552,1,ARGATROBAN IN SODIUM CHLORIDE,N209552,Prescription,AUROBINDO PHARMA LTD,SOLUTION (INTRAVENOUS),50MG/50ML (1MG/ML),ARGATROBAN,Letter,2018-12-19T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/209552Orig1s000ltr.pdf
209604,1,GEMCITABINE HYDROCHLORIDE,N209604,Prescription,ACCORD HLTHCARE,SOLUTION (INTRAVENOUS),200MG/2ML (100MG/ML),GEMCITABINE HYDROCHLORIDE,Label,2017-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209604s000lbl.pdf
209604,2,GEMCITABINE HYDROCHLORIDE,N209604,Prescription,ACCORD HLTHCARE,SOLUTION (INTRAVENOUS),1GM/10ML (100MG/ML),GEMCITABINE HYDROCHLORIDE,Label,2017-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209604s000lbl.pdf
209604,3,GEMCITABINE HYDROCHLORIDE,N209604,Prescription,ACCORD HLTHCARE,SOLUTION (INTRAVENOUS),1.5GM/15ML (100MG/ML),GEMCITABINE HYDROCHLORIDE,Label,2017-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209604s000lbl.pdf
209604,4,GEMCITABINE HYDROCHLORIDE,N209604,Prescription,ACCORD HLTHCARE,SOLUTION (INTRAVENOUS),2GM/20ML (100MG/ML),GEMCITABINE HYDROCHLORIDE,Label,2017-08-04T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209604s000lbl.pdf
209949,1,DAPTOMYCIN,N209949,Prescription,XELLIA PHARMS APS,POWDER (IV (INFUSION)),350MG/VIAL,DAPTOMYCIN,Letter,2017-10-23T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209949Orig1s000ltr.pdf
210737,1,REDITREX,N210737,Prescription,CUMBERLAND PHARMS,SOLUTION (SUBCUTANEOUS),7.5MG/0.3ML (7.5MG/0.3ML),METHOTREXATE,Label,2019-11-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf
210737,2,REDITREX,N210737,Prescription,CUMBERLAND PHARMS,SOLUTION (SUBCUTANEOUS),10MG/0.4ML (10MG/0.4ML),METHOTREXATE,Label,2019-11-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf
210737,3,REDITREX,N210737,Prescription,CUMBERLAND PHARMS,SOLUTION (SUBCUTANEOUS),12.5MG/0.5ML (12.5MG/0.5ML),METHOTREXATE,Label,2019-11-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf
210737,4,REDITREX,N210737,Prescription,CUMBERLAND PHARMS,SOLUTION (SUBCUTANEOUS),15MG/0.6ML (15MG/0.6ML),METHOTREXATE,Label,2019-11-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf
210737,5,REDITREX,N210737,Prescription,CUMBERLAND PHARMS,SOLUTION (SUBCUTANEOUS),17.5MG/0.7ML (17.5MG/0.7ML),METHOTREXATE,Label,2019-11-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf
210737,6,REDITREX,N210737,Prescription,CUMBERLAND PHARMS,SOLUTION (SUBCUTANEOUS),20MG/0.8ML (20MG/0.8ML),METHOTREXATE,Label,2019-11-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf
210737,7,REDITREX,N210737,Prescription,CUMBERLAND PHARMS,SOLUTION (SUBCUTANEOUS),22.5MG/ML (22.5MG/ML),METHOTREXATE,Label,2019-11-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf
210737,8,REDITREX,N210737,Prescription,CUMBERLAND PHARMS,SOLUTION (SUBCUTANEOUS),25MG/1ML (25MG/1ML),METHOTREXATE,Label,2019-11-29T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf
210821,1,TETRACAINE HYDROCHLORIDE,N210821,Prescription,BAUSCH LOMB IRELAND,SOLUTION (OPHTHALMIC),0.50%,TETRACAINE HYDROCHLORIDE,Label,2019-03-13T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210821s000lbl.pdf
210997,1,GLYRX-PF,N210997,Prescription,EXELA PHARMA,"SOLUTION (INTRAMUSCULAR, INTRAVENOUS)",0.2MG/ML (0.2MG/ML),GLYCOPYRROLATE,Label,2018-07-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210997s000lbl.pdf
210997,2,GLYRX-PF,N210997,Prescription,EXELA PHARMA,"SOLUTION (INTRAMUSCULAR, INTRAVENOUS)",0.4MG/2ML (0.2MG/ML),GLYCOPYRROLATE,Label,2018-07-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210997s000lbl.pdf
210997,3,GLYRX-PF,N210997,Prescription,EXELA PHARMA,"SOLUTION (INTRAMUSCULAR, INTRAVENOUS)",1MG/5ML (0.2MG/ML),GLYCOPYRROLATE,Label,2018-07-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210997s000lbl.pdf
210997,4,GLYRX-PF,N210997,Prescription,EXELA PHARMA,"SOLUTION (INTRAMUSCULAR, INTRAVENOUS)",0.6MG/3ML (0.2MG/ML),GLYCOPYRROLATE,Label,2018-07-12T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210997s000lbl.pdf
211215,1,ANGIOMAX RTU,N211215,Prescription,MAIA PHARMS INC,SOLUTION (INTRAVENOUS),250MG/50ML (5MG/ML),BIVALIRUDIN,Letter,2019-07-26T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211215Orig1s000ltr.pdf
211226,1,KHAPZORY,N211226,Prescription,ACROTECH,POWDER (INTRAVENOUS),175MG/VIAL,LEVOLEUCOVORIN,Label,2018-10-22T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211226s000lbl.pdf
211226,2,KHAPZORY,N211226,Prescription,ACROTECH,POWDER (INTRAVENOUS),300MG/VIAL,LEVOLEUCOVORIN,Label,2018-10-22T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211226s000lbl.pdf
211284,1,TEMIXYS,N211284,Prescription,CELLTRION,TABLET (ORAL),300MG;300MG,LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE,Pediatric DD Summary Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/357_211284 lamivudine-tenofovir DD clinical prea.pdf
211843,1,THIOLA EC,N211843,Prescription,MISSION PHARMACAL CO,"TABLET, DELAYED RELEASE (ORAL)",100MG,TIOPRONIN,Letter,2019-07-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211843Orig1s000ltr.pdf
211843,2,THIOLA EC,N211843,Prescription,MISSION PHARMACAL CO,"TABLET, DELAYED RELEASE (ORAL)",300MG,TIOPRONIN,Letter,2019-07-01T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211843Orig1s000ltr.pdf
211939,1,BONSITY,N211939,Prescription,ALVOGEN,SOLUTION (SUBCUTANEOUS),0.62MG/2.48ML (0.25MG/ML),TERIPARATIDE,Label,2019-10-07T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211939s000lbl.pdf
212020,1,TRANEXAMIC ACID,N212020,Prescription,EXELA PHARMA,SOLUTION (INTRAVENOUS),1GM/100ML (10MG/ML),TRANEXAMIC ACID,Label,2019-04-19T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212020lbl.pdf
212832,1,POTASSIUM PHOSPHATES,N212832,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML),"POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",Label,2019-11-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212832s000lbl.pdf
212832,2,POTASSIUM PHOSPHATES,N212832,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML),"POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",Label,2019-11-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212832s000lbl.pdf
212832,3,POTASSIUM PHOSPHATES,N212832,Prescription,FRESENIUS KABI USA,SOLUTION (INTRAVENOUS),11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML),"POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",Label,2019-11-27T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212832s000lbl.pdf
212895,1,CONJUPRI,N212895,Discontinued,CSPC OUYI,TABLET (ORAL),EQ 1.25MG BASE,LEVAMLODIPINE MALEATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/520_212895 levamlodipine clinical prea.pdf
212895,2,CONJUPRI,N212895,Prescription,CSPC OUYI,TABLET (ORAL),EQ 2.5MG BASE,LEVAMLODIPINE MALEATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/520_212895 levamlodipine clinical prea.pdf
212895,3,CONJUPRI,N212895,Prescription,CSPC OUYI,TABLET (ORAL),EQ 5MG BASE,LEVAMLODIPINE MALEATE,Pediatric Medical Review,1900-01-01T00:00:00Z,https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/520_212895 levamlodipine clinical prea.pdf
212909,1,BIORPHEN,N212909,Prescription,ETON PHARMS,SOLUTION (INTRAVENOUS),0.5MG/5ML (0.1MG/ML),PHENYLEPHRINE HYDROCHLORIDE,Label,2019-10-22T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212909s000lbl.pdf
212909,2,BIORPHEN,N212909,Discontinued,ETON PHARMS,SOLUTION (INTRAVENOUS),10MG/ML (10MG/ML),PHENYLEPHRINE HYDROCHLORIDE,Label,2019-10-22T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212909s000lbl.pdf
213407,1,EMERPHED,N213407,Prescription,NEXUS PHARMS,SOLUTION (INTRAVENOUS),50MG/10ML (5MG/ML),EPHEDRINE SULFATE,Label,2020-04-20T00:00:00Z,http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213407s000lbl.pdf
